<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6054270 - Patterning of oligonucleotides on surface of support; attaching ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Patterning of oligonucleotides on surface of support; attaching oligonucleotides to impervious surface at known locations with computer controlled apparatus"><meta name="DC.contributor" content="Edwin Southern" scheme="inventor"><meta name="DC.contributor" content="Oxford Gene Technology Limited" scheme="assignee"><meta name="DC.date" content="1997-9-9" scheme="dateSubmitted"><meta name="DC.description" content="This invention provides an apparatus and method for analyzing a polynucleotide sequence; either an unknown sequence or a known sequence. A support, e.g. a glass plate, carries an array of the whole or a chosen part of a complete set of oligonucleotides which are capable of taking part in hybridization reactions. The array may comprise one or more pair of oligonucleotides of chosen lengths. The polynucleotide sequence, or fragments thereof, are labelled and applied to the array under hybridizing conditions. Applications include analyses of known point mutations, genomic fingerprinting, linkage analysis, characterization of mRNAs, mRNA populations, and sequence determination."><meta name="DC.date" content="2000-4-25" scheme="issued"><meta name="DC.relation" content="CA:1284931" scheme="references"><meta name="DC.relation" content="EP:0063810:A1" scheme="references"><meta name="DC.relation" content="EP:0130523:A2" scheme="references"><meta name="DC.relation" content="EP:0130739:A2" scheme="references"><meta name="DC.relation" content="EP:0142299:A2" scheme="references"><meta name="DC.relation" content="EP:0171150" scheme="references"><meta name="DC.relation" content="EP:0194132:A2" scheme="references"><meta name="DC.relation" content="EP:0228075:A2" scheme="references"><meta name="DC.relation" content="EP:0235726:A2" scheme="references"><meta name="DC.relation" content="EP:0237362:A1" scheme="references"><meta name="DC.relation" content="EP:0238332:A2" scheme="references"><meta name="DC.relation" content="EP:0268237:A2" scheme="references"><meta name="DC.relation" content="EP:0281927:A2" scheme="references"><meta name="DC.relation" content="EP:0392546:A2" scheme="references"><meta name="DC.relation" content="GB:2156074" scheme="references"><meta name="DC.relation" content="US:4216245" scheme="references"><meta name="DC.relation" content="US:4327073" scheme="references"><meta name="DC.relation" content="US:4395486" scheme="references"><meta name="DC.relation" content="US:4563419" scheme="references"><meta name="DC.relation" content="US:4656127" scheme="references"><meta name="DC.relation" content="US:4704353" scheme="references"><meta name="DC.relation" content="US:4728502" scheme="references"><meta name="DC.relation" content="US:4888278" scheme="references"><meta name="DC.relation" content="US:4994373" scheme="references"><meta name="DC.relation" content="US:5002867" scheme="references"><meta name="DC.relation" content="US:5164319" scheme="references"><meta name="DC.relation" content="US:5202231" scheme="references"><meta name="DC.relation" content="US:5445934" scheme="references"><meta name="DC.relation" content="US:5527681" scheme="references"><meta name="DC.relation" content="US:5677195" scheme="references"><meta name="DC.relation" content="US:5700637" scheme="references"><meta name="DC.relation" content="US:5744305" scheme="references"><meta name="DC.relation" content="US:5807522" scheme="references"><meta name="DC.relation" content="US:5925525" scheme="references"><meta name="DC.relation" content="WO:1984003151:A1" scheme="references"><meta name="DC.relation" content="WO:1984003564:A1" scheme="references"><meta name="DC.relation" content="WO:1985001051:A1" scheme="references"><meta name="DC.relation" content="WO:1986000991:A1" scheme="references"><meta name="DC.relation" content="WO:1986003782:A1" scheme="references"><meta name="DC.relation" content="WO:1986006487:A1" scheme="references"><meta name="DC.relation" content="WO:1988001302:A1" scheme="references"><meta name="DC.relation" content="WO:1989011548:A1" scheme="references"><meta name="DC.relation" content="WO:1993022480:A1" scheme="references"><meta name="citation_reference" content="(Sep. 1988)."><meta name="citation_reference" content="A. Palva et al., DNA, 7(2), 135 142 (1988)."><meta name="citation_reference" content="A. Palva et al., DNA, 7(2), 135-142 (1988)."><meta name="citation_reference" content="A. Rosenthal, Nucleic Acids Research, 13(4), 1173 1184 (1985)."><meta name="citation_reference" content="A. Rosenthal, Nucleic Acids Research, 13(4), 1173-1184 (1985)."><meta name="citation_reference" content="A.R. Brautigam et al., J. Clin. Microbiol., 12(2), 226 234 (1980)."><meta name="citation_reference" content="A.R. Brautigam et al., J. Clin. Microbiol., 12(2), 226-234 (1980)."><meta name="citation_reference" content="A.R. Dunn et al., Cell, 12, 23 26 (1977)."><meta name="citation_reference" content="A.R. Dunn et al., Cell, 12, 23-26 (1977)."><meta name="citation_reference" content="B. Lewin, Genes, 3rd Ed., John Wiley &amp; Sons, pp. 360 362 (1983)."><meta name="citation_reference" content="B. Lewin, Genes, 3rd Ed., John Wiley &amp; Sons, pp. 360-362 (1983)."><meta name="citation_reference" content="Brigati et al., Virology, vol. 126, pp. 32 50, 1983."><meta name="citation_reference" content="Brigati et al., Virology, vol. 126, pp. 32-50, 1983."><meta name="citation_reference" content="Bunemann et al. Nucleic Acids Research, 10(22), 7163 7180 (1982)."><meta name="citation_reference" content="Bunemann et al. Nucleic Acids Research, 10(22), 7163-7180 (1982)."><meta name="citation_reference" content="Bunemann Nucleic Acids Research, 10(22), 7181 7196 (1982)."><meta name="citation_reference" content="Bunemann Nucleic Acids Research, 10(22), 7181-7196 (1982)."><meta name="citation_reference" content="C.G. Miyada et al., Methods in Enzymology, 154, 94 107 (1987)."><meta name="citation_reference" content="C.G. Miyada et al., Methods in Enzymology, 154, 94-107 (1987)."><meta name="citation_reference" content="C.R. Cantor et al., Genomics, 13, 1378 1383 (1992)."><meta name="citation_reference" content="C.R. Cantor et al., Genomics, 13, 1378-1383 (1992)."><meta name="citation_reference" content="Church et al., Science, 240, 185 188 (Apr. 8, 1988)."><meta name="citation_reference" content="Church et al., Science, 240, 185-188 (Apr. 8, 1988)."><meta name="citation_reference" content="Dean et al., Journal of Clinical Microbiology, 27(5), 1062 1067 (May 1989)."><meta name="citation_reference" content="Dean et al., Journal of Clinical Microbiology, 27(5), 1062-1067 (May 1989)."><meta name="citation_reference" content="E. Calva et al., J. Biol. Chem., 255(22), 11011 11016 (1980)."><meta name="citation_reference" content="E. Calva et al., J. Biol. Chem., 255(22), 11011-11016 (1980)."><meta name="citation_reference" content="E.M. Southern et al., Genomics, 13, 1008 1017 (1992)."><meta name="citation_reference" content="E.M. Southern et al., Genomics, 13, 1008-1017 (1992)."><meta name="citation_reference" content="Ezaki et al., Cancer, 61, 106 109 (1988)."><meta name="citation_reference" content="Ezaki et al., Cancer, 61, 106-109 (1988)."><meta name="citation_reference" content="Ezaki et al., FEMS Microbiology Letters, 67, 127 130 (1990)."><meta name="citation_reference" content="Ezaki et al., FEMS Microbiology Letters, 67, 127-130 (1990)."><meta name="citation_reference" content="Ezaki et al., International Journal of Systematic Bacteriology, 36(2), 345 347 (1986)."><meta name="citation_reference" content="Ezaki et al., International Journal of Systematic Bacteriology, 36(2), 345-347 (1986)."><meta name="citation_reference" content="Ezaki et al., J. Gen. Appl. Microbiol., 34, 191 199 (1988)."><meta name="citation_reference" content="Ezaki et al., J. Gen. Appl. Microbiol., 34, 191-199 (1988)."><meta name="citation_reference" content="Ezaki et al., Journal of Clinical Microbiology, 26(9), 1708 1713"><meta name="citation_reference" content="Ezaki et al., Journal of Clinical Microbiology, 26(9), 1708-1713"><meta name="citation_reference" content="Ezaki et al., Microbiol. Immunol., 32(2), 141 150 (1988)."><meta name="citation_reference" content="Ezaki et al., Microbiol. Immunol., 32(2), 141-150 (1988)."><meta name="citation_reference" content="Ezaki, Asian Med. J., 34(8), 454 459 (1991)."><meta name="citation_reference" content="Ezaki, Asian Med. J., 34(8), 454-459 (1991)."><meta name="citation_reference" content="F. Kafatos et al., Nucleic Acids Research, 7(6), 1541 1552 (1979)."><meta name="citation_reference" content="F. Kafatos et al., Nucleic Acids Research, 7(6), 1541-1552 (1979)."><meta name="citation_reference" content="Farrow et al., System. Appl. Microbiol., 5, 467 482 (1984)."><meta name="citation_reference" content="Farrow et al., System. Appl. Microbiol., 5, 467-482 (1984)."><meta name="citation_reference" content="Fodor et al., Science, vol. 251, pp. 767 773, 1991."><meta name="citation_reference" content="Fodor et al., Science, vol. 251, pp. 767-773, 1991."><meta name="citation_reference" content="Forster et al. Nucleic Acids Research, 13(3), 745 761 (1985)."><meta name="citation_reference" content="Forster et al. Nucleic Acids Research, 13(3), 745-761 (1985)."><meta name="citation_reference" content="Frankel et al., The Journal of Infectious Diseases, 161 1252 1256 (1990)."><meta name="citation_reference" content="Frankel et al., The Journal of Infectious Diseases, 161 1252-1256 (1990)."><meta name="citation_reference" content="G. Beltz et al., Methods in Enzymology, 100, 266 285 (1983)."><meta name="citation_reference" content="G. Beltz et al., Methods in Enzymology, 100, 266-285 (1983)."><meta name="citation_reference" content="G. Wengler et al., Virology, 78, 124 134 (1977)."><meta name="citation_reference" content="G. Wengler et al., Virology, 78, 124-134 (1977)."><meta name="citation_reference" content="G.K. Sim et al., Cell, 18, 1303 1316 (1979)."><meta name="citation_reference" content="G.K. Sim et al., Cell, 18, 1303-1316 (1979)."><meta name="citation_reference" content="G.M. Church et al., Proc. Natl. Acad. Sci. USA, 81, 1991 1995 (1984)."><meta name="citation_reference" content="G.M. Church et al., Proc. Natl. Acad. Sci. USA, 81, 1991-1995 (1984)."><meta name="citation_reference" content="Ghosh et al. Farrow et al., System. Appl. Microbiol., 5, 483 493 (1984)."><meta name="citation_reference" content="Ghosh et al. Farrow et al., System. Appl. Microbiol., 5, 483-493 (1984)."><meta name="citation_reference" content="Gingeras et al. Nucleic Acids Research, 15(13), 5373 5390 (1987)."><meta name="citation_reference" content="Gingeras et al. Nucleic Acids Research, 15(13), 5373-5390 (1987)."><meta name="citation_reference" content="Gingeras, T.R., et al., &quot;Nucleic Acids Research&quot;, 15(13), 5373-5390 (1987)."><meta name="citation_reference" content="Gingeras, T.R., et al., Nucleic Acids Research , 15(13), 5373 5390 (1987)."><meta name="citation_reference" content="Gingeres et al., Nucleic Acids Research, vol. 15, No. 13, pp. 5373 5390 (1987)."><meta name="citation_reference" content="Gingeres et al., Nucleic Acids Research, vol. 15, No. 13, pp. 5373-5390 (1987)."><meta name="citation_reference" content="Graham et al., Gene, vol. 48, pp. 241 249, 1986."><meta name="citation_reference" content="Graham et al., Gene, vol. 48, pp. 241-249, 1986."><meta name="citation_reference" content="H.M. Geysen et al., J. Immun. Meth., 102, 259 274 (1987)."><meta name="citation_reference" content="H.M. Geysen et al., J. Immun. Meth., 102, 259-274 (1987)."><meta name="citation_reference" content="Habermehl, Ed., Rapid Methods and Automation in Microbiology and Immunology, 30 33 (1985)."><meta name="citation_reference" content="Habermehl, Ed., Rapid Methods and Automation in Microbiology and Immunology, 30-33 (1985)."><meta name="citation_reference" content="J.M. Coffin et al., Cell, 13, 761 773 (1978)."><meta name="citation_reference" content="J.M. Coffin et al., Cell, 13, 761-773 (1978)."><meta name="citation_reference" content="Kilpper Balz et al., System. Appl. Microbiol., 5, 494 500 (1984)."><meta name="citation_reference" content="Kilpper-Balz et al., System. Appl. Microbiol., 5, 494-500 (1984)."><meta name="citation_reference" content="Koomey et al., Infection and Immunity, 43(1), 101 107 (Jan. 1984)."><meta name="citation_reference" content="Koomey et al., Infection and Immunity, 43(1), 101-107 (Jan. 1984)."><meta name="citation_reference" content="L.J. Arnold et al., Federation Proceedings, 43(7), Abstract No. 3669 (1984)."><meta name="citation_reference" content="M. Anderson et al., Nucleic Acid Hybridisation, A Practical Approach, B.D. Hames et al., IRL Press, pp. 73 111 (1985)."><meta name="citation_reference" content="M. Anderson et al., Nucleic Acid Hybridisation, A Practical Approach, B.D. Hames et al., IRL Press, pp. 73-111 (1985)."><meta name="citation_reference" content="M.S. Urdea et al., Gene, 61, 253 264 (1987)."><meta name="citation_reference" content="M.S. Urdea et al., Gene, 61, 253-264 (1987)."><meta name="citation_reference" content="McDonough et al., Journal of Clinical Microbiology, 26(12), 2515 2519 (1988)."><meta name="citation_reference" content="McDonough et al., Journal of Clinical Microbiology, 26(12), 2515-2519 (1988)."><meta name="citation_reference" content="Moseley et al., Advances in Research on Cholera and Related Diarrheas, 207 216 (1983)."><meta name="citation_reference" content="Moseley et al., Advances in Research on Cholera and Related Diarrheas, 207-216 (1983)."><meta name="citation_reference" content="Nagata et al., FEBS Letters, 183(2), 379 382 (Apr. 1985)."><meta name="citation_reference" content="Nagata et al., FEBS Letters, 183(2), 379-382 (Apr. 1985)."><meta name="citation_reference" content="Nucleic Acids Research, 15(13), 5353 5372 (1987)."><meta name="citation_reference" content="Nucleic Acids Research, 15(13), 5353-5372 (1987)."><meta name="citation_reference" content="Ogle et al., The Journal of Infectious Diseases, 155(1), 119 126 (Jan. 1987)."><meta name="citation_reference" content="Ogle et al., The Journal of Infectious Diseases, 155(1), 119-126 (Jan. 1987)."><meta name="citation_reference" content="P. Masinkoswki et al., Nucleic Acids Research, 10(24), 7895 7903 (1982)."><meta name="citation_reference" content="P. Masinkoswki et al., Nucleic Acids Research, 10(24), 7895-7903 (1982)."><meta name="citation_reference" content="Potter et al., Gene, vol. 48, pp. 229 239, 1986."><meta name="citation_reference" content="Potter et al., Gene, vol. 48, pp. 229-239, 1986."><meta name="citation_reference" content="R. Drmanac et al., &quot;Sequencing of Megabase Plus DNA by Hybridization: Theory of the Method&quot;, University of Belgrade (former Yugoslavia) (1988)."><meta name="citation_reference" content="R. Drmanac et al., Sequencing of Megabase Plus DNA by Hybridization: Theory of the Method , University of Belgrade (former Yugoslavia) (1988)."><meta name="citation_reference" content="R. Frank, Methods in Enzymology , 154, 221 251 (1987)."><meta name="citation_reference" content="R. Frank, Methods in Enzymology, 154, 221-251 (1987)."><meta name="citation_reference" content="R. Frank, Nucleic Acids Research, 11(13), 4365 4377 (1983)."><meta name="citation_reference" content="R. Frank, Nucleic Acids Research, 11(13), 4365-4377 (1983)."><meta name="citation_reference" content="R.K. Saiki et al., Nature, 324, 163 166 (1986)."><meta name="citation_reference" content="R.K. Saiki et al., Nature, 324, 163-166 (1986)."><meta name="citation_reference" content="Robins Browne et al., Journal of Clinical Microbiology, 27(4), 644 650 (Apr. 1989)."><meta name="citation_reference" content="Robins-Browne et al., Journal of Clinical Microbiology, 27(4), 644-650 (Apr. 1989)."><meta name="citation_reference" content="Saiki et al., Nature, vol. 324, pp. 163 166, 1986."><meta name="citation_reference" content="Saiki et al., Nature, vol. 324, pp. 163-166, 1986."><meta name="citation_reference" content="Schachter, Diagn. Microbiol. Infect. Dis., 4, 185 189 (1986)."><meta name="citation_reference" content="Schachter, Diagn. Microbiol. Infect. Dis., 4, 185-189 (1986)."><meta name="citation_reference" content="Starnbach, Journal of Clinical Microbiology, 27(6), 1257 1261 (Jun. 1989)."><meta name="citation_reference" content="Starnbach, Journal of Clinical Microbiology, 27(6), 1257-1261 (Jun. 1989)."><meta name="citation_reference" content="Syvanen, Medical Biology, 64, 313 324 (1986) (Review Article)."><meta name="citation_reference" content="Syvanen, Medical Biology, 64, 313-324 (1986) (Review Article)."><meta name="citation_reference" content="T. Maniatis et al., Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory, p. 282 (1982)."><meta name="citation_reference" content="Tenover, Clinical Microbiology Reviews, 1(1), 82 101 (Jan. 1988)."><meta name="citation_reference" content="Tenover, Clinical Microbiology Reviews, 1(1), 82-101 (Jan. 1988)."><meta name="citation_reference" content="U.B. Voss et al., Biochemical Society Transactions, 624th Meeting, Dublin, 216 217 (1987)."><meta name="citation_reference" content="U.B. Voss et al., Biochemical Society Transactions, 624th Meeting, Dublin, 216-217 (1987)."><meta name="citation_reference" content="V.J. Kidd et al., Nature, 304, 230 234 (1983)."><meta name="citation_reference" content="V.J. Kidd et al., Nature, 304, 230-234 (1983)."><meta name="citation_reference" content="W. Bains et al., J. Theor. Biol., 135, 303 307 (1988)."><meta name="citation_reference" content="W. Bains et al., J. Theor. Biol., 135, 303-307 (1988)."><meta name="citation_reference" content="Wood et al., Proc. Natl. Acad. Sci. (USA), vol. 82, pp. 1585 1588, 1985."><meta name="citation_reference" content="Wood et al., Proc. Natl. Acad. Sci. (USA), vol. 82, pp. 1585-1588, 1985."><meta name="citation_reference" content="Y.P. Lysov et al., Dokl. Akad., 303, 1508 1511 (1988) (with English translation)."><meta name="citation_reference" content="Y.P. Lysov et al., Dokl. Akad., 303, 1508-1511 (1988) (with English translation)."><meta name="citation_patent_number" content="US:6054270"><meta name="citation_patent_application_number" content="US:08/925,676"><link rel="canonical" href="http://www.google.com/patents/US6054270"/><meta property="og:url" content="http://www.google.com/patents/US6054270"/><meta name="title" content="Patent US6054270 - Patterning of oligonucleotides on surface of support; attaching oligonucleotides to impervious surface at known locations with computer controlled apparatus"/><meta name="description" content="This invention provides an apparatus and method for analyzing a polynucleotide sequence; either an unknown sequence or a known sequence. A support, e.g. a glass plate, carries an array of the whole or a chosen part of a complete set of oligonucleotides which are capable of taking part in hybridization reactions. The array may comprise one or more pair of oligonucleotides of chosen lengths. The polynucleotide sequence, or fragments thereof, are labelled and applied to the array under hybridizing conditions. Applications include analyses of known point mutations, genomic fingerprinting, linkage analysis, characterization of mRNAs, mRNA populations, and sequence determination."/><meta property="og:title" content="Patent US6054270 - Patterning of oligonucleotides on surface of support; attaching oligonucleotides to impervious surface at known locations with computer controlled apparatus"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("XqDtU7TvC6PEsQTFtIDABw"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("USA"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("XqDtU7TvC6PEsQTFtIDABw"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("USA"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6054270?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6054270"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=y-xOBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6054270&amp;usg=AFQjCNFgtUSbK5jnQi69tlFMcWGKF_b2fQ" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6054270.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6054270.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6054270" style="display:none"><span itemprop="description">This invention provides an apparatus and method for analyzing a polynucleotide sequence; either an unknown sequence or a known sequence. A support, e.g. a glass plate, carries an array of the whole or a chosen part of a complete set of oligonucleotides which are capable of taking part in hybridization...</span><span itemprop="url">http://www.google.com/patents/US6054270?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6054270 - Patterning of oligonucleotides on surface of support; attaching oligonucleotides to impervious surface at known locations with computer controlled apparatus</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6054270 - Patterning of oligonucleotides on surface of support; attaching oligonucleotides to impervious surface at known locations with computer controlled apparatus" title="Patent US6054270 - Patterning of oligonucleotides on surface of support; attaching oligonucleotides to impervious surface at known locations with computer controlled apparatus"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6054270 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/925,676</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Apr 25, 2000</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Sep 9, 1997</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">May 3, 1988</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Lapsed</td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">08925676, </span><span class="patent-bibdata-value">925676, </span><span class="patent-bibdata-value">US 6054270 A, </span><span class="patent-bibdata-value">US 6054270A, </span><span class="patent-bibdata-value">US-A-6054270, </span><span class="patent-bibdata-value">US6054270 A, </span><span class="patent-bibdata-value">US6054270A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Edwin+Southern%22">Edwin Southern</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Oxford+Gene+Technology+Limited%22">Oxford Gene Technology Limited</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6054270.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6054270.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6054270.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (43),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (131),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (208),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (34),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (9)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6054270&usg=AFQjCNGZQJsAOHCGeuDnXmRTfRqFggpWtQ">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6054270&usg=AFQjCNFxhB5W1hSA992rmQpudX_H0_eaug">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6054270A%26KC%3DA%26FT%3DD&usg=AFQjCNESVrMMsuch_DuKsdQcapyi3TyTlg">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT129104351" lang="EN" load-source="ifi">Patterning of oligonucleotides on surface of support; attaching oligonucleotides to impervious surface at known locations with computer controlled apparatus</invention-title></span><br><span class="patent-number">US 6054270 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA38061639" lang="EN" load-source="patent-office"> <div class="abstract">This invention provides an apparatus and method for analyzing a polynucleotide sequence; either an unknown sequence or a known sequence. A support, e.g. a glass plate, carries an array of the whole or a chosen part of a complete set of oligonucleotides which are capable of taking part in hybridization reactions. The array may comprise one or more pair of oligonucleotides of chosen lengths. The polynucleotide sequence, or fragments thereof, are labelled and applied to the array under hybridizing conditions. Applications include analyses of known point mutations, genomic fingerprinting, linkage analysis, characterization of mRNAs, mRNA populations, and sequence determination.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(22)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-8.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-8.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-9.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-9.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-10.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-10.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-11.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-11.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-12.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-12.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-13.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-13.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-14.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-14.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-15.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-15.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-16.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-16.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-17.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-17.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-18.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-18.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-19.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-19.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-20.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-20.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6054270-21.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6054270-21.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(12)</span></span></div><div class="patent-text"><div mxw-id="PCLM59564034" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>I claim:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. A method of making an array of oligonucleotides, which comprises:<div class="claim-text">attaching a plurality of oligonucleotides to an impermeable surface of a support, the oligonucleotides having different predetermined sequences and being attached at different known locations on the surface of the support through a computer-controlled printing device.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. The method as claimed in claim 1, wherein stripes of oligonucleotides, corresponding to allelic variants of a polynucleotide to be probed, are attached to the impermeable surface of the support.</div>
    </div>
    </div> <div class="claim"> <div num="3" class="claim">
      <div class="claim-text">3. A method for constructing an array of oligonucleotides of length s and composed of different nucleotides, which method comprises:<div class="claim-text">a) applying precursors for the different nucleotides separately to a plurality of different regions of a surface,</div> <div class="claim-text">b) applying precursors for the different nucleotides separately to a plurality of different regions amongst the plurality of different regions defined in a),</div> <div class="claim-text">c) repeating the process until each of said regions contains oligonucleotides of length s.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. The method as claimed in claim 3, wherein the number of different nucleotides utilized is 4.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" class="claim">
      <div class="claim-text">5. The method as claimed in claim 3, where s is 8-20.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" class="claim">
      <div class="claim-text">6. The method as claimed in claim 3, wherein the regions are organized on the surface in rows and columns.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" class="claim">
      <div class="claim-text">7. The method as claimed in claim 3, wherein the precursors are applied through a computer-controlled printing device.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" class="claim">
      <div class="claim-text">8. The method as claimed in claim 3, wherein each region is at least 100 microns wide.</div>
    </div>
    </div> <div class="claim"> <div num="9" class="claim">
      <div class="claim-text">9. A method of analysing a polynucleotide, which method comprises:<div class="claim-text">applying a labelled polynucleotide to be analysed or fragments thereof to an array of oligonucleotides under hybridisation conditions, wherein the array comprises a support having an impermeable surface to which a plurality of oligonucleotides having different predetermined sequences are attached to different known regions on the surface, and</div> <div class="claim-text">analysing the polynucleotide by observing the regions where the polynucleotide or fragment thereof hybridizes and the regions where the polynucleotide or fragment thereof does not hybridize.</div> </div>
    </div>
    </div> <div class="claim"> <div num="10" class="claim">
      <div class="claim-text">10. A method of comparing polynucleotide sequences, which method comprises:<div class="claim-text">applying the polynucleotides to an array of oligonucleotides under hybridizing conditions, wherein the oligonucleotides have different predetermined sequences and are attached at different known locations on an impermeable surface of a support, and</div> <div class="claim-text">observing the differences between the patterns of hybridisation.</div> </div>
    </div>
    </div> <div class="claim"> <div num="11" class="claim">
      <div class="claim-text">11. A method for analysing multiple sequences in multiple polynucleotides, which comprises:<div class="claim-text">a) laying down stripes of oligonucleotides corresponding to each sequence on the surface of an impermeable solid support,</div> <div class="claim-text">b) applying the polynucleotides to the surface under hybridisation conditions in stripes orthogonal to those of the oligonucleotides,</div> <div class="claim-text">c) observing hybridisation at a site of intersection as an indication of the presence of a sequence in the polynucleotide.</div> </div>
    </div>
    </div> <div class="claim"> <div num="12" class="claim">
      <div class="claim-text">12. An array of oligonucleotides comprising a support having an impermeable surface to which a plurality of oligonucleotides are attached, the oligonucleotides having different nucleotide sequences and being attached at different known locations on the surface of the support, wherein each oligonucleotide has the sequence N<sub>m</sub> AATAAAN<sub>n</sub> or its complement where N is any nucleotide residue and m+n is at least about 8.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES67461708" lang="EN" load-source="patent-office" class="description">
    <p>This is a divisional application of Ser. No. 08/230,012, filed Apr. 19, 1994, now U.S. Pat. No. 5,700,637; which is a continuation of abandoned application Ser. No. 07/695,682, filed May 3, 1991, which is a continuation-in-part of abandoned application Ser. No. 07/573,317, filed Sep. 28, 1990, which is a 371 of PCT/GB89/00460, filed May 2, 1989.</p>
    <heading>1. INTRODUCTION</heading> <p>Three methods dominate molecular analysis of nucleic acid sequences: gel electrophoresis of restriction fragments, molecular hybridisation, and the rapid DNA sequencing methods. These three methods have a very wide range of applications in biology, both in basic studies, and in the applied areas of the subject such as medicine and agriculture. Some idea of the scale on which the methods are now used is given by the rate of accumulation of DNA sequences, which is now well over one million base pairs a year. However, powerful as they are, they have their limitations. The restriction fragment and hybridisation methods give a coarse analysis of an extensive region, but are rapid; sequence analysis gives the ultimate resolution, but it is slow, analysing only a short stretch at a time. There is a need for methods which are faster than the present methods, and in particular for methods which cover a large amount of sequence in each analysis.</p>
    <p>This invention provides a new approach which produces both a fingerprint and a partial or complete sequence in a single analysis, and may be used directly with complex DNAs and populations of RNA without the need for cloning.</p>
    <p>In one aspect the invention provides apparatus for analysing a polynucleotide sequence, comprising a support and attached to a surface thereof an array of the whole or a chosen part of a complete set of oligo nucleotides of chosen lengths, the different oligonucleotides occupying separate cells of the array and being capable of taking part in hybridisation reactions. For studying differences between polynucleotide sequences, the invention provides in another aspect apparatus comprising a support and attached to a surface thereof an array of the whole or a chosen part of a complete set of oligonucleotides of chosen lengths comprising the polynucleotide sequences, the different oligonucleotides occupying separate cells of the array and being capable of taking part in hybridisation reactions.</p>
    <p>In another aspect, the invention provides a method of analysing a polynucleotide sequence, by the use of a support to the surface of which is attached an array of the whole or a chosen part of a complete set of oligo nucleotides of chosen lengths, the different oligonucleotides occupying separate cells of the array, which method comprises labelling the polynucleotide sequence or fragments thereof to form labelled material, applying the labelled material under hybridisation conditions to the array, and observing the location of the label on the surface associated with particular members of the set of oligonucleotides.</p>
    <p>The idea of the invention is thus to provide a structured array of the whole or a chosen part of a complete set of oligonucleotides of one or several chosen lengths. The array, which may be laid out on a supporting film or glass plate, forms the target for a hybridisation reaction. The chosen conditions of hybridisation and the length of the oligonucleotides must at all events be sufficient for the available equipment to be able to discriminate between exactly matched and mismatched oligonucleotides. In the hybridisation reaction, the array is explored by a labelled probe, which may comprise oligomers of the chosen length or longer polynucleotide sequences or fragments, and whose nature depends on the particular application. For example, the probe may comprise labelled sequences amplified from genomic DNA by the polymerase chain reaction, or a mRNA population, or a complete set of oligonucleotides from a complex sequence such as an entire genome. The end result is a set of filled cells corresponding to the oligonucleotides present in the analysed sequence, and a set of "empty" sites corresponding to the sequences which are absent in the analysed sequence. The pattern produces a fingerprint representing all of the sequence analysed. In addition, it is possible to assemble most or all of the sequence analysed if an oligonucleotide length is chosen such that most or all oligonucleotide sequences occur only once.</p>
    <p>The number, the length and the sequences of the oligonucleotides present in the array "lookup table" also depend on the application. The array may include all possible oligonucleotides of the chosen length, as would be required if there was no sequence information on the sequence to be analysed. In this case, the preferred length of oligonucleotide used depends on the length of the sequence to be analysed, and is such that there is likely to be only one copy of any particular oligomer in the sequence to be analysed. Such arrays are large. If there is any information available on the sequence to be analysed, the array may be a selected subset. For the analysis of a sequence which is known, the size of the array is of the same order as length of the sequence, and for many applications, such as the analysis of a gene for mutations, it can be quite small. These factors are discussed in detail in what follows.</p>
    <heading>2. OLIGONUCLEOTIDES AS SEQUENCE PROBES</heading> <p>Oligonucleotides form base paired duplexes with oligonucleotides which have the complementary base sequence. The stability of the duplex is dependent on the length of the oligonucleotides and on base composition. Effects of base composition on duplex stability can be greatly reduced by the presence of high concentrations of quarternary or tertiary amines. However, there is a strong effect of mismatches in the oligonucleotides duplex on the thermal stability of the hybrid, and it is this which takes the technique of hybridisation with oligonucleotides such a powerful method for the analysis of mutations, and for the selection of specific sequences for amplification by DNA polymerase chain reaction. The position of the mismatch affects the degree of destabilisation. Mismatches in the centre of the duplex may cause a lowering of the Tm by 10° C. compared with 1° C. for a terminal mismatch. There is then a range of discriminating power depending on the position of mismatch, which has implications for the method described here. There are ways of improving the discriminating power, for example by carrying out hybridisation close to the Tm of the duplex to reduce the rate of formation of mismatched duplexes, and by increasing the length of oligonucleotide beyond what is required for unique representation. A way of doing this systematically is discussed.</p>
    <heading>3. ANALYSIS OF A PREDETERMINED SEQUENCE</heading> <p>One of the most powerful uses of oligonucleotide probes has been in the detection of single base changes in human genes. The first example was the detection of the single base change in the betaglobin gene which leads to sickle cell disease. There is a need to extend this approach to genes in which there may be a number of different mutations leading to the same phenotype, for example the DMD gene and the HPRT gene, and to find an efficient way of scanning the human genome for mutations in regions which have been shown by linkage analysis to contain a disease locus for example Huntington's disease and Cystic Fibrosis. Any known sequence can be represented completely as a set of overlapping oligonucleotides. The size of the set is N s+1≈N, where N is the length of the sequence and s is the length of an oligomer. A gene of 1 kb for example, may be divided into an overlapping set of around one thousand oligonucleotides of any chosen length. An array constructed with each of these oligonucleotides in a separate cell can be used as a multiple hybridisation probe to examine the homologous sequence in any context, a single-copy gene in the human genome or a messenger RNA among a mixed RNA population, for example. The length s may be chosen such that there is only a small probability that any oligomer in the sequence is represented elsewhere in the sequence to be analysed. This can be estimated from the expression given in the section discussing statistics below. For a less complete analysis it would be possible to reduce the size of the array e.g. by a factor of up to 5 by representing the sequence in a partly or non-overlapping set. The advantage of using a completely overlapping set is that it provides a more precise location of any sequence difference, as the mismatch will scan in s consecutive oligonucleotides.</p>
    <heading>4. ANALYSIS OF AN UNDETERMINED SEQUENCE</heading> <p>The genomes of all free living organisms are larger than a million base pairs and none has yet been sequenced completely. Restriction site mapping reveals only a small part of the sequence, and can detect only a small portion of mutations when used to compare two genomes. More efficient methods for analysing complex sequences are needed to bring the full power of molecular genetics to bear on the many biological problems for which there is no direct access to the gene or genes involved. In many cases, the full sequence of the nucleic acids need not be determined; the important sequences are those which differ between two nucleic acids. To give three examples: the DNA sequences which are different between a wild type organism and one which carries a mutant can lead the way to isolation of the relevant gene; similarly, the sequence differences between a cancer cell and its normal counterpart can reveal the cause of transformation; and the RNA sequences which differ between two cell types point to the functions which distinguish them. These problems can be opened to molecular analysis by a method which identifies sequence differences. Using the approach outlined here, such differences can be revealed by hybridising the two nucleic acids, for example the genomic DNA of the two genotypes, or the mRNA populations of two cell types to an array of oligonucleotides which represent all possible sequences. Positions in the array which are occupied by one sequence but not by the other show differences in two sequences. This gives the sequence information needed to synthesise probes which can then be used to isolate clones of the sequence involved.</p>
    <heading>4.1 Assembling the Sequence Information</heading> <p>Sequences can be reconstructed by examining the result of hybridisation to an array. Any oligonucleotides of length s from within a long sequence, overlaps with two others over a length s-1. Starting from each positive oligonucleotide, the array may be examined for the four oligonucleotides to the left and the four to the right that can overlap with a one base displacement. If only one of these four oligonucleotides is found to be positive to the right, then the overlap and the additional base to the right determine s bases in the unknown sequence. The process is repeated in both directions, seeking unique matches with other positive oligonucleotides in the array. Each unique match adds a base to the reconstructed sequence.</p>
    <heading>4.2 Some Statistics</heading> <p>Any sequence of length N can be broken down to a set of ˜N overlapping sequences s base pairs in length. (For double stranded nucleic acids, the sequence complexity of a sequence of N base pairs is 2N, because the two strands have different sequences, but for the present purpose, this factor of two is not significant). For oligonucleotides of length s, there are 4<sup>s</sup> different sequence combinations. How big should s be to ensure that most oligonucleotides will be represented only once in the sequence to be analysed, of complexity N? For a random sequence the expected number of s-mers which will be present in more than one copy is</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">μ&gt;1≈4'(1-e<sup>-</sup>λ (1+λ))</pre>
    
    <p>where</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">λ=(N-s+1)/4'</pre>
    
    <p>For practical reasons it is also useful to know how many sequences are related to any given s-mer by a single base change. Each position can be substituted by one of three bases, there are therefore 3s sequences related to an individual s-mer by a single base change, and the probability that any s-mer in a sequence of N bases is related to any other s-mer in that sequence allowing one substitution is 3s×N/4<sup>2</sup>. The relative signals of matched and mismatched sequences will then depend on how good the hybridisation conditions are in distinguishing a perfect match from one which differ by a single base. (If 4<sup>s</sup> is an order of magnitude greater than N, there should only be a few, 3s/10, related to any oligonucleotide by one base change.) The indications are that the yield of hybrid from the mismatched sequence is a fraction of that formed by the perfect duplex.</p>
    <p>For what follows, it is assumed that conditions can be found which allow oligonucleotides which have complements in the probe to be distinguished from those which do not.</p>
    <heading>4.3 Array Format, Construction and Size</heading> <p>To form an idea of the scale of the arrays needed to analyse sequences of different complexity it is convenient to think of the array as a square matrix. All sequences of a given length can be represented just once in a matrix constructed by drawing four rows representing the four bases, followed by four similar columns. This produces a 4×4 matrix in which each of the 16 squares represents one of the 16 doublets. Four similar matrices, but one quarter the size, are then drawn within each of the original squares. This produces a 16×16 matrix containing all 256 tetranucleotide sequences. Repeating this process produces a matrix of any chosen depth, s, with a number of cells equal to 4<sup>s</sup>. As discussed above, the choice of s is of great importance, as it determines the complexity of the sequence representation. As discussed below, s also determines the size of the matrix constructed, which must be very big for complex genomes. Finally, the length of the oligonucleotides determines the hybridisation conditions and their discriminating power as hybridisation probes.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________                    Side of Matrix                              Number of  s 4<sup>s</sup> Genomes (pixel = 100 μm) Sheets of film______________________________________ 8   65536    4<sup>s</sup> x<sup>10</sup>   9 262144  10 1.0 × 10<sup>6</sup> cosmid 100 mm 1  11 4.2 × 10<sup>6</sup>  12 1.7 × 10<sup>7</sup>  13 6.7 × 10<sup>7</sup> E. coli  14 2.6 × 10<sup>8</sup> yeast 1.6 m 9  15 1.1 × 10<sup>9</sup>  16 4.2 × 10<sup>9</sup>  17 1.7 × 10<sup>10</sup>  18 6.7 × 10<sup>10</sup> human 25 m 2,500  19 2.7 × 10<sup>11</sup>  20 1.1 × 10<sup>12</sup>  100 m______________________________________</pre>
    
    <p>The table shows the expected scale of the arrays needed to perform the first analysis of a few genomes. The examples were chosen because they are genomes which have either been sequenced by conventional procedures--the cosmid scale--, are in the process of being sequences--the E. coli scale--, or for which there has been considerable discussion of the magnitude of the problem--the human scale. The table shows that the expected scale of the matrix approach is only a small fraction of the conventional approach. This is readily seen in the area of X-ray film that would be consumed. It is also evident that the time taken for the analysis would be only a small fraction of that needed for gel methods. The "Genomes" column shows the length of random sequence which would fill about 5% of cells in the matrix. This has been determined to be the optimum condition for the first step in the sequencing strategy discussed below. At this size, a high proportion of the positive signals would represent single occurrences of each oligomer, the conditions needed to compare two genomes for sequence differences.</p>
    <heading>5. REFINEMENT OF AN INCOMPLETE SEQUENCE</heading> <p>Reconstruction of a complex sequence produces a result in which the reconstructed sequence is interrupted at any point where an oligomer that is repeated in the sequence occurs. Some repeats are present as components of long repeating structures which form part of the structural organisation of the DNA, dispersed and tandem repeats in human DNA for example. But when the length of oligonucleotide used in the matrix is smaller than that needed to give totally unique sequence representation, repeats occur by chance. Such repeats are likely to be isolated. That is, the sequences surrounding the repeated oligomers are unrelated to each other. The gaps caused by these repeats can be removed by extending the sequence to longer oligomers. In principle, those sequences shown to be repeated by the first analysis, using an array representation of all possible oligomers, could be resynthesised with an extension at each end. For each repeated oligomer, there would be 4×4=16 oligomers in the new matrix. The hybridisation analysis would now be repeated until the sequence was complete. In practice, because the results of a positive signal in the hybridisation may be ambiguous, it may be better to adopt a refinement of the first result by extending all sequences which did not give a clear negative result in the first analysis. An advantage of this approach is that extending the sequence brings mismatches which are close to the ends in the shorter oligomer, closer to the centre in the extended oligomer, increasing the discriminatory power of duplex formation.</p>
    <heading>5.1 A Hypothetical Analysis of the Sequence of Bacteriophage λ DNA</heading> <p>Lambda phage DNA is 48,502 base pairs long. Its sequence has been completely determined, we have treated one strand of this as a test case in a computer simulation of the analysis. The table shows that the appropriate size of oligomer to use for a sequence of this complexity is the 10-mer. With a matrix of 10-mers, the size was 1024 lines square. After "hybridisation" of the lambda 10-mers in the computer, 46,377 cells were positive, 1957 had double occurrences, 75 triple occurrences, and three quadruple occurrences. These 46,377 positive cells represented known sequences, determined from their position in the matrix. Each was extended by four×one base at the 3' end and four×one base at the 5', end to give 16×46,377=742,032 cells. This extended set reduced the number of double occurrences to 161, a further 16-fold extension brought the number down to 10, and one more provided a completely overlapped result. Of course, the same end result of a fully overlapped sequence could be achieved starting with a 4<sup>16</sup> matrix, but the matrix would be 4000 times bigger than the matrix needed to represent all 10-mers, and most of the sequence represented on it would be redundant.</p>
    <heading>5.2 Laying Down the Matrix</heading> <p>The method described here envisages that the matrix will be produced by synthesising oligonucleotides in the cells of an array by laying down the precursors for the four bases in a predetermined pattern, an example of which is described above. Automatic equipment for applying the precursors has yet to be developed, but there are obvious possibilities; it should not be difficult to adapt a pen plotter or other computer-controlled printing device to the purpose. The smaller the pixel size of the array the better, as complex genomes need very large numbers of cells. However, there are limits to how small these can be made. 100 microns would be a fairly comfortable upper limit, but could probably not be achieved on paper for reasons of texture and diffusion. On a smooth impermeable surface, such as glass, it may be possible to achieve a resolution of around 10 microns, for example by using a laser typesetter to preform a solvent repellant grid, and building the oligonucleotides in the exposed regions. One attractive possibility, which allows adaptation of present techniques of oligonucleotide synthesis, is to sinter microporous glass in microscopic patches onto the surface of a glass plate. Laying down very large number of lines or dots could take a long time, if the printing mechanism were slow. However, a low cost inkjet printer can print at speeds of about 10,000 spots per second. With this sort of speed, 10<sup>8</sup> spots could be printed in about three hours.</p>
    <heading>5.3 Oligonucleotide Synthesis</heading> <p>There are several methods of synthesising oligonucleotides. Most methods in current use attach the nucleotides to a solid support of controlled pore size glass (CPG) and are suitable for adaptation to synthesis on a glass surface. Although we know of no description of the direct use of oligonucleotides as hybridisation probes while still attached to the matrix on which they were synthesised, there are reports of the use of oligonucleotides as hybridisation probes on solid supports to which they were attached after synthesis. PCT Application WO 85/01051 describes a method for synthesising oligonucleotides tethered to a CPG column. In an experiment performed by us, CPG was used as the support in an Applied Bio-systems oligonucleotide synthesiser to synthesise a 13-mer complementary to the left hand cos site of phage lambda. The coupling steps were all close to theoretical yield. The first base was stably attached to the support medium through all the synthesis and deprotection steps by a covalent link.</p>
    <heading>5.4 Analysing Several Sequences Simultaneously</heading> <p>The method of this invention can be used to analyse several polynucleotide sequences simultaneously. To achieve this, the oligonucleotides may be attached to the support in the form of (for example) horizontal stripes. A technique for doing this is described in Example 3 below. Each DNA sample to be analysed is labelled and applied to the surface carrying the oligonucleotides in the form of a stripe (e.g. vertical) orthogonal to the oligonucleotide stripes of the array. Hybridisation is seen at the intersections between oligonucleotide stripes and stripes of test sequence where there is homology between them.</p>
    <p>Where sequence variations are known, an advantage of using this technique is that many different mutations can be probed simultaneously by laying down stripes corresponding to each allelic variant. With a density of one oligonucleotide per mm, and one "individual" per 5 mm, it should be possible to analyse 2000 loci on a plate 100 mm square. Such a high density of information, where the oligonucleotides do identify specific alleles, is not available by other techniques.</p>
    <heading>6. PROBES, HYBRIDISATION AND DETECTION</heading> <p>The yield of oligonucleotides synthesised on microporous glass is about 30 μmol/g. A patch of this material 1 micron thick by 10 microns square would hold  3×10<sup>-12</sup> μmol, equivalent to about 2 g of human DNA. The hybridisation reaction could therefore be carried out with a very large excess of the bound oligonucleotides over that in the probe. So it should be possible to design a system capable of distinguishing between hybridisation involving single and multiple occurrances of the probe sequence, as yield will be proportional to concentration at all stages in the reaction.</p>
    <p>The polynucleotide sequence to be analysed may be of DNA or RNA. To prepare the probe, the polynucleotide may be degraded to form fragments. Preferably it is degraded by a method which is as random as possible, to an average length around the chosen length s of the oligonucleotides on the support, and oligomers of exact length s selected by electrophoresis on a sequencing gel. The probe is then labelled. For example, oligonucleotides of length s may be end labelled. If labelled with <sup>32</sup> P, the radioactive yield of any individual s-mer even from total human DNA could be more than 10<sup>4</sup> dpm/mg of total DNA. For detection, only a small fraction of this is needed in a patch 10-100 microns square. This allows hybridisation conditions to be chosen to be close to the Tm of duplexes, which decreases the yield of hybrid and decreases the rate of formation, but increases the discriminating power. Since the bound oligonucleotide is in excess, signal need not be a problem even working close to equilibrium.</p>
    <p>Hybridisation conditions can be chosen to be those known to be suitable in standard procedures used to hybridise to filters, but establishing optimum conditions is important. In particular, temperature needs to be controlled closely, preferably to better than ±0.5° C. Particularly when the chosen length of the oligonucleotide is small, the analysis needs to be able to distinguish between slight differences of rate and/or extent of hybridisation. The equipment may need to be programmed for differences in base composition between different oligonucleotides. In constructing the array, it may be preferable to partition this into sub-matrices with similar base compositions. This may make it easier to define the Tm which may differ slightly according to the base composition.</p>
    <p>The choice of hybridisation solvent is significant. When 1M NaCl is used, G:C base pairs are more stable than A:T base pairs. Double stranded oligonucleotides with a high G+C content have a higher Tm than corresponding oligonucleotides with a high A+T content. This discrepancy can be compensated in various ways: the amount of oligonucleotide laid down on the surface of the support can be varied depending on its nucleotide composition; or the computer used to analyse the data can be programmed to compensate for variations in nucleotide composition. A preferred method, which can be used either instead of or in addition to those already mentioned, is to use a chaotropic hybridisation solvent, for example a quarternary or tertiary amine as mentioned above. Tetramethylammoniumchloride (TMACl) has proved particularly suitable, at concentrations in the range 2 M to 5.5 M. At TMACl concentrations around 3.5 M to 4 M, the T<sub>m</sub> dependence on nucleotide composition is greatly reduced.</p>
    <p>The nature of the hybridisation salt used also has a major effect on the overall hybridisation yield. Thus, the use of TMACl at concentrations up to 5 M can increase the overall hybridisation yield by a factor of 30 or more (the exact figure depending to some extent on nucleotide composition) in comparison with hybridisation using 1M NaCl. Manifestly, this has important implications; for example the amount of probe material that needs to be used to achieve a given signal can be much lower.</p>
    <p>Autoradiography, especially with <sup>32</sup> P causes image degradation which may be a limiting factor determining resolution; the limit for silver halide films is around 25 microns. Obviously some direct detection system would be better. Fluorescent probes are envisaged; given the high concentration of the target oligonucleotides, the low sensitivity of fluorescence may not be a problem.</p>
    <p>We have considerable experience of scanning autoradiographic images with a digitising scanner. Our present design is capable of resolution down to 25 microns, which could readily be extended down to less than present application, depending on the quality of the hybridisation reaction, and how good it is at distinguishing absence of a sequence from the presence of one or more. Devices for measuring astronomical plates have an accuracy around 1 μ. Scan speeds are such that a matrix of several million cells can be scanned in a few minutes. Software for the analysis of the data is straight-forward, though the large data sets need a fast computer.</p>
    <p>Experiments presented below demonstrate the feasibility of the claims.</p>
    <p>Commercially available microscope slides (BDH Super Premium 76×26×1 mm) were used as supports. These were derivatised with a long aliphatic linker that can withstand the conditions used for the deprotection of the aromatic heterocyclic bases, i.e. 30% NH<sub>3</sub> at 55° for 10 hours. The linker, bearing a hydroxyl group which serves as a starting point for the subsequent oligonucleotide, is synthesised in two steps. The slides are first treated with a 25% solution of 3-glycidoxypropyltriethoxysilane in xylene containing several drops of Hunig's base as a catalyst. The reaction is carried out in a staining jar, fitted with a drying tube, for 20 hours at 90° C. The slides are washed with MeOH, Et<sub>2</sub> O and air dried. Then neat hexaethylene glycol and a trace amount of conc. sulphuric acid are added and the mixture kept at 80° for 20 hours. The slides are washed with MeOH, Et<sub>2</sub> O, air dried and stored desiccated at -20° until use. This preparative technique is described in British Patent Application 8822228.6 filed Sep. 21, 1988.</p>
    <p>The oligonucleotide synthesis cycle is performed as follows:</p>
    <p>The coupling solution is made up fresh for each step by mixing 6 vol. of 0.5M tetrazole in anhydrous acetonitrile with 6 vol. of a 0.2M solution of the required beta-cyanoethylphosphoramidite. Coupling time is three minutes. Oxidation with a 0.1M solution of I<sub>2</sub> in THF/pyridine/H<sub>2</sub> O yields a stable phosphotriester bond. Detritylation of the 5' end with 3% trichloroacetic acid in dichloromethane allows further extension of the oligonucleotide chain. There was no capping step since the excess of phosphoramidites used over reactive sites on the slide was large enough to drive the coupling to completion. After the synthesis is completed, the oligonucleotide is deprotected in 30% NH<sub>3</sub> for 10 hours at 55°. The chemicals used in the coupling step are moisture-sensitive, and this critical step must be performed under anhydrous conditions in a sealed container, as follows. The shape of the patch to be synthesised was cut out of a sheet of silicone rubber (76×26×0.5 mm) which was sandwiched between a microscope slide, derivatised as described above, and a piece of teflon of the same size and thickness. To this was fitted a short piece of plastic tubing that allowed us to inject and withdraw the coupling solution by syringe and to flush the cavity with Argon. The whole assembly was held together by fold-back paper clips. After coupling the set-up was disassembled and the slide put though the subsequent chemical reactions (oxidation with iodine, and detritylation by treatment with TCA) by dipping it into staining jars.</p>
    <heading>EXAMPLE 1</heading> <p>As a first example we synthesised the sequences oligo-dT<sub>10</sub> -oligo-dT<sub>14</sub> on a slide by gradually decreasing the level of the coupling solution in steps 10 to 14. Thus the 10-mer was synthesised on the upper part of the slide, the 14-mer at the bottom and the 11, 12 and 13-mers were in between. We used 10 pmol oligo-dA<sub>12</sub>, labelled at the 5' end with <sup>32</sup> P by the polynucleotide kinase reaction to a total activity of 1.5 million c.p.m., as a hybridisation probe. Hybridisation was carried out in a perspex (Plexiglas) container made to fit a microscope slide, filled with 1.2 ml of 1M NaCl in TE, 0.1% SDS, for 5 minutes at 20°. After a short rinse in the same solution without oligonucleotide, we were able to detect more than 2000 c.p.s. with a radiation monitor. An autoradiograph showed that all the counts came from the area where the oligonucleotide had been synthesised, i.e. there was no non-specific binding to the glass or to the region that had been derivatised with the linker only. After partial elution in 0.1 M NaCl differential binding to the target is detectable, i.e. less binding to the shorter than the longer oligo-dT. By gradually heating the slide in the wash solution we determined the T<sub>m</sub> (midpoint of transition when 50% eluted) to be 33°. There were no counts detectable after incubation at 39°. The hybridisation and melting was repeated eight times with no diminution of the signal. The result is reproducible. We estimate that at least 5% of the input counts were taken up by the slide at each cycle.</p>
    <heading>EXAMPLE 2</heading> <p>In order to determine whether we would be able to distinguish between matched and mismatched oligonucleotides we synthesised two sequences 3' CCC GCC GCT GGA (cos L) and 3' CCC GCC TCT GGA, which differ by one base at position 7. All bases except the seventh were added in a rectangular patch. At the seventh base, half of the rectangle was exposed in turn to add the two different bases, in two stripes. Hybridisation of cos R probe oligonucleotide (5' GGG CGG CGA CCT) (kinase labelled with <sup>32</sup> P to 1.1 million c.p.m., 0.1 M NaCl, TE, 0.1% SDS) was for 5 hours at 32°. The front of the slide showed 100 c.p.s. after rinsing. Autoradiography showed that annealing occurred only to the part of the slide with the fully complementary oligonucleotide. No signal was detectable on the patch with the mismatched sequence.</p>
    <heading>EXAMPLE 3</heading> <p>For a further study of the effects of mismatches or shorter sequences on hybridisation behaviour, we constructed two arrays; one (a) of 24 oligonucleotides and the other (b) of 72 oligonucleotides.</p>
    <p>These arrays were set out as shown in Table 1(a) and 1(b). The masks used to lay down these arrays were different from those used in previous experiments. Lengths of silicone rubber tubing (1 mm o.d.) were glued with silicone rubber cement to the surface of plain microscope slides, in the form of a "U". Clamping these masks against a derivatised microscope slide produced a cavity into which the coupling solution was introduced through a syringe. In this way only the part of the slide within the cavity came into contact with the phosphoramidite solution. Except in the positons of the mismatched bases, the arrays listed in Table 1 were laid down using a mask which covered most of the width of the slide. Off-setting this mask by 3 mm up or down the derivatised slide in subsequent coupling reactions produced the oligonucleotides truncated at the 3' or 5' ends.</p>
    <p>For the introduction of mismatches a mask was used which covered half (for array (a)) or one third (for array (b)) of the width of the first mask. The bases at positions six and seven were laid down in two or three longitudinal stripes. This led to the synthesis of oligonucleotides differing by one base on each half (array (a)) or third (array (b)) of the slide. In other positions, the sequences differed from the longest sequence by the absence of bases at the ends.</p>
    <p>In array (b), there were two columns of sequences between those shown in Table 1(b), in which the sixth and seventh bases were missing in all positions, because the slide was masked in a stripe by the silicone rubber seal. Thus there were a total of 72 different sequences represented on the slide in 90 different positions.</p>
    <p>The 19-mer 5' CTC CTG AGG AGA AGT CTG C was used for hybridisation (2 million cpm, 1.2 ml 0.1M NaCl in TE, 0.1% SDS, 20°).</p>
    <p>The washing and elution steps were followed by autoradiography. The slide was kept in the washing solution for 5 min at each elution step and then exposed (45 min, intensified). Elution temperatures were 23, 36, 42, 47, 55 and 60° C. respectively.</p>
    <p>As indicated in the table, the oligonucleotides showed different melting behaviour. Short oligonucleotides melted before longer ones, and at 55° C., only the perfectly matched 19-mer was stable, all other oligonucleotides had been eluted. Thus the method can differentiate between a 18-mer and a 19-mer which differ only by the absence of one base at the end. Mismatches at the end of the oligonucleotides and at internal sites can all be melted under conditions where the perfect duplex remains.</p>
    <p>Thus we are able to use very stringent hybridisation conditions that eliminate annealing to mismatch sequences or to oligonucleotides differing in length by as little as one base. No other method using hybridisation of oligonucleotides bound to the solid supports is so sensitive to the effects of mismatching.</p>
    <heading>EXAMPLE 4</heading> <p>To test the application of the invention to diagnosis of inherited diseases, we hybridised the array (a), which carries the oligonucleotide sequences specific for the wild type and the sickle cell mutations of the β-globin gene, with a 110 base pair fragment of DNA amplified from the β-globin gene by means of the polymerase chain reaction (PCR). Total DNA from the blood of a normal individual (1 microgram) was amplified by PCR in the presence of appropriate primer oligonucleotides. The resulting 110 base pair fragment was purified by electrophoresis through an agarose gel. After elution, a small sample (ca. 10 picogram) was labelled by using ∝-<sup>32</sup> P-dCTP (50 microCurie) in a second PCR reaction. This PCR contained only the upstream priming oligonucleotide. After 60 cycles of amplification with an extension time of 9 min. the product was removed from precursors by gel filtration. Gel electrophoresis of the radioactive product showed a major band corresponding in length to the 110 base fragment. One quarter of this produce (100,000 c.p.m. in 0.9 M NaCl, TE, 0.1% SDS) was hybridised to the array (a). After 2 hours at 30° ca. 15000 c.p.m. had been taken up. The melting behaviour of the hybrids was followed as described for the 19-mer in example 3, and it was found that the melting behaviour was similar to that of the oligonucleotide. That is to say, the mismatches considerably reduced the melting temperature of the hybrids, and conditions were readily found such that the perfectly matched duplex remained whereas the mismatched duplexes had fully melted.</p>
    <p>Thus the invention can be used to analyse long fragments of DNA as well oligonucleotides, and this example shows how it may be used to test nucleic acid sequences for mutations. In particular it shows how it may be applied to the diagnosis of genetic diseases.</p>
    <heading>EXAMPLE 5</heading> <p>To test an automated system for laying down the precursors, the cos L oligonucleotide was synthesised with 11 of the 12 bases added in the way described above. For the addition of the seventh base, however, the slide was transferred into an Argon filled chamber containing a pen plotter. The pen of the plotter had been replaced by a component, fabricated from Nylon, which had the same shape and dimensions as the pen, but which carried a polytetrafluoroethylene (PTFE) tube, through which chemicals could be delivered to the surface of the glass slide which lay on the bed of the plotter. A microcomputer was used to control the plotter and the syringe pump which delivered the chemicals. The pen, carrying the delivery tube from the syringe, was moved into position above the slide, the pen was lowered and the pump activated to lay down coupling solution. Filling the pen successively with G, T and A phosphoramidite solutions an array of twelve spots was laid down in three groups of four, with three different oligonucleotide sequences. After hybridisation to cos R, as described in Example 2, and autoradiography, signal was seen only over the four spots of perfectly matched oligonucleotides, where the dG had been added.</p>
    <heading>EXAMPLE 6</heading> <p>This example demonstrates the technique of analysing several DNA sequences simultaneously. Using the technique described in Example 3, a slide was prepared bearing six parallel rows of oligonucleotides running along its length. These comprised duplicate hexadecamer sequences corresponding to antisense sequences of the β-globin wild-type (A), sickle cell (S) and C mutations.</p>
    <p>Clinical samples of AC, AS and SS DNA were procured. Three different single-stranded probes of 110 nt length with approx. 70,000 c.p.m. in 100 μl 1M NaCl, TE pH 7.5, 0.1% SDS, viz AC, AS, and SS DNA were prepared. Radiolabelled nucleotide was included in the standard PCR step yielding a double-stranded labelled fragment. It was made single-stranded with Bacteriophage λ exonuclease that allowed to selectively digest one strand bearing a 5' phosphate. This was made possible by phosphorylating the downstream primer with T4 Polynucleotide kinase and (`cold`) ATP prior to PCR. These three probes were applied as three stripes orthogonal to the surface carrying the six oligonucleotide stripes. Incubation was at 30° C. for 2 hours in a moist chamber. The slide was then rinsed at ambient temperature, then 45° C. for 5 minutes and exposed for 4 days with intensification. The genotype of each clinical sample was readily determined from the autoradiographic signals at the points of intersection.</p>
    <heading>EXAMPLE 7</heading> <p>A plate was prepared whose surface carried an array of all 256 octapurines. That is to say, the array comprised 256 oligonucleotides each consisting of a different sequence of A and G nucleotides. This array was probed with a mixture comprising all 256 octapyrimidines, each end labelled by means of polynucleotide kinase and γ-<sup>32</sup> P-ATP. Hybridisation was performed for 6-8 hours at 4° C.</p>
    <p>In consecutive experiments the hybridisation solvent was changed through the series 1M NaCl (containing 10 mM Tris.HCl pH 7.5, 1 mM EDTA, 7% sarcosine) and 2M, 2.5M, 3M, 3.5M, 4M, 4.5M, 5M and 5.5M TMACl (all containing 50 mM Tris.HCl pH 8.0, 2 mM EDTA, SDS at less than 0.04 mg/ml). The plate was rinsed for 10 minutes at 4° C. in the respective solvent to remove only loosely matched molecules, sealed in a plastic bag and exposed to a PhorphorImager storage phosphor screen at 4° C. overnight in the dark.</p>
    <p>The following table quotes relative signal intensities, at a given salt concentration, of hybrids formed with oligonucleotides of varying a content. In this table, the first row refers to the oligonucleotide GGGGGGGG, and the last row to the oligonucleotide AAAAAAAA. It can be seen that the difference in response of these two oligonucleotides is marked in 1M NaCl, but much less marked in 3M or 4M TMACl.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Relative Intensities at given Salt Concentration      Number of A'sSolvent    0             4      8______________________________________1M NaCl    100            30    20  2M TMACl 100  70 30  3M TMACl  70 100 40  4M TMACl  60 100 40______________________________________</pre>
    
    <p>The following table indicates relative signal intensities obtained, with octamers containing 4A's and 4G's, at different hybridisation salt concentrations. It can be seen that the signal intensity is dramatically increased at higher concentrations of TMACl.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Relative Intensities at different Salt Concentrations   Solvent   Yield of hybrid______________________________________1M NaCl       100  2M TMACl 200  3M TMACl 700  4M TMACl 2000______________________________________</pre>
    
    <p>In conclusion, we have demonstrated the following:</p>
    <p>1. It is possible to synthesise oligonucleotides in good yield on a flat glass plate.</p>
    <p>2. Multiple sequences can be synthesised on the sample in small spots, at high density, by a simple manual procedure, or automatically using a computer controlled device.</p>
    <p>3. Hybridisation to the oligonucleotides on the plate can be carried out by a very simple procedure. Hybridisation is efficient, and hybrids can be detected by a short autoradiographic exposure.</p>
    <p>4. Hybridisation is specific. There is no detectable signal on areas of the plate where there are no oligonucleotides. We have tested the effects of mismatched bases, and found that a single mismatched base at any position in oligonucleotides ranging in length from 12-mer to 19-mer reduces the stability of the hybrid sufficiently that the signal can be reduced to a very low level, while retaining significant hybridisation to the perfectly matched hybrid.</p>
    <p>5. The oligonucleotides are stably bound to the glass and plates can be used for hybridisation repeatedly.</p>
    <p>The invention thus provides a novel way of analysing nucleotide sequences, which should find a wide range of application. We list a number of potential applications below:</p>
    <heading>Small Arrays of Oligonucleotides as Fingerprinting and Mapping Tools</heading> <p>Analysis of known mutations including genetic diseases</p>
    <p>Example 4 above shows how the invention may be used to analyse mutations. There are many applications for such a method, including the detection of inherited diseases.</p>
    <p>Genomic fingerprinting</p>
    <p>In the same way as mutations which lead to disease can be detected, the method could be used to detect point mutations in any stretch of DNA. Sequences are now available for a number of regions containing the base differences which lead to restriction fragment length polymorphisms (RFLPs). An array of oligonucleotides representing such polymorphisms could be made from pairs of oligonucleotides representing the two allelic restriction sites. Amplification of the sequence containing the RFLP, followed by hybridisation to the plate, would show which alleles were present in the test genome. The number of oligonucleotides that could be analysed in a single analysis could be quite large. Fifty pairs made from selected alleles would be enough to give a fingerprint unique to an individual.</p>
    <p>Linkage analysis</p>
    <p>Applying the method described in the last paragraph to a pedigree would pinpoint recombinations. Each pair of spots in the array would give the information that is seen in the track of the RFLP analysis, using gel electrophoresis and blotting, that is now routinely used for linkage studies. It should be possible to analyse many alleles in a single analysis, by hybridisation to an array of allelic pairs of oligonucleotides, greatly simplifying the methods used to find linkage between a DNA polymorphism and phenotypic marker such as a disease gene.</p>
    <p>The examples above could be carried out using the method we have developed and confirmed by experiments.</p>
    <heading>Large Arrays of Oligonucleotides as Sequence Reading Tools</heading> <p>We have shown that oligonucleotides can be synthesised in small patches in precisely determined positions by one of two methods: by delivering the precursors through the pen of a pen-plotter, or by masking areas with silicone rubber. It is obvious how a pen plotter could be adapted to synthesise larger arrays with a different sequence in each position. For some applications the array should be a predetermined, limited set; for other applications, the array should comprise every sequence of a predetermined length. The masking method can be used for the latter by laying down the precursors in a mask which produces intersecting lines. There are many ways in which this can be done and we give one example for illustration:</p>
    <p>1. The first four bases, A, C, G, T, are laid in four broad stripes on a square plate.</p>
    <p>2. The second set is laid down in four stripes equal in width to the first, and orthogonal to them. The array is now composed of all sixteen dinucleotides.</p>
    <p>3. The third and fourth layers are laid down in four sets of four stripes one quarter the width of the first stripes. Each set of four narrow stripes runs within one of the broader stripes. The array is now composed of all 256 tetranucleotides.</p>
    <p>4. The process is repeated, each time laying down two layers with stripes which are one quarter the width of the previous two layers. Each layer added increases the length of the oligonucleotides by one base, and the number of different oligonucleotide sequences by a factor of four.</p>
    <p>The dimensions of such arrays are determined by the width of the stripes. The narrowest stripe we have laid is 1 mm, but this is clearly not the lowest limit.</p>
    <p>There are useful applications for arrays in which part of the sequence is predetermined and part made up of all possible sequences. For example:</p>
    <p>Characterising mRNA populations</p>
    <p>Most mRNAs in higher eukaryotes have the sequence AAUAAA close to the 3' end. The array used to analyse mRNAs would have this sequence all over the plate. To analyse a mRNA population it would be hybridised to an array composed of all sequences of the type N<sub>m</sub> AATAAAN<sub>n</sub>. For m+n=8, which should be enough to give a unique oligonucleotide address to most of the several thousand mRNAs that is estimated to be present in a source such as a mammalian cell, the array would be 256 elements square. The 256×256 elements would be laid on the AATAAA using the masking method described above. With stripes of around 1 mm, the array would be ca. 256 mm square.</p>
    <p>This analysis would measure the complexity of the mRNA population and could be used as a basis for comparing populations from different cell types. The advantage of this approach is that the differences in the hybridisation pattern would provide the sequence of oligonucleotides that could be used as probes to isolate all the mRNAs that differed in the populations.</p>
    <p>Sequence determination</p>
    <p>To extend the idea to determine unknown sequences, using an array composed of all possible oligonucleotides of a chosen length, requires larger arrays than we have synthesised to date. However, it is possible to scale down the size of spot and scale up the numbers to those required by extending the methods we have developed and tested on small arrays. Our experience shows that the method is much simpler in operation than the gel based methods.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">                                  TABLE 1__________________________________________________________________________For Examples 3 and 4 array (a) was set out as follows:  20 GAG GAC TCC TCT ACG       20 GAG GAC aCC TCT ACG  36 GAG GAC TCC TCT GAC G     20 GAC GAC aCC TCT GAC G  36 GAG GAC TCC TCT AGA CG    20 GAC GAC aCC TCT AGA CG  47 GAG GAC TCC TCT CAG ACG   36 GAG GAC aCC TCT CAG ACG  60 GAG GAC TCC TCT TCA GAC G 47 GAG GAC aCC TCT TCA GAC G  56 .AG GAC TCC TCT TCA GAC G 42 .AG GAC aCC TCT TCA GAC G  56 ..G GAC TCC TCT TCA GAC G 42 ..G GAC aCC TCT TCA GAC G  47 ... GAC TCC TCT TCA GAC G 42 ... GAC aCC TCT TCA GAC G  42 ... .AC TCC TCT TCA GAC G 36 ... .AC aCC TCT TCA GAC G  36 ... ..C TCC TCT TCA GAC G 36 ... ..C aCC TCT TCA GAC G  36 ... ... TCC TCT TCA GAC G 36 ... ... aCC TCT TCA GAC G  36 ... ... .CC TCT TCA GAC G 36 ... ... .CC TCT TCA GAC G  For example 3 array (b) was set out as follows:  20 GAG GAt TC                20 GAG GAC TC                20 GAG GAC aC  20 GAG GAt TCC               20 GAG GAC TCC               20 GAG GAC                                                aCC  20 GAG GAt TCC T             20 GAG GAC TCC T             20 GAG GAC                                                aCC T  20 GAG GAt TCC TC            20 GAG GAC TCC TC            20 GAG GAC                                                aCC TC  20 GAG GAt TCC TCT           20 GAG GAC TCC TCT           20 GAG GAC                                                aCC TCT  20 GAC GAt TCC TCT T         20 GAG GAC TCC TCT T         20 GAG GAC                                                aCC TCT T  20 GAG GAt TCC TCT TC        20 GAG GAC TCC TCT TC        20 GAG GAC                                                aCC TCT TC  20 GAG GAt TCC TCT TCA       20 GAG GAC TCC TCT TCA       20 GAG GaC                                                aCC TCT TCA  32 GAG GAt TCC TCT TCA G     42 GAG GAC TCC TCT TCA G     20 GAG GAC                                                aCC TCT TCA G                                                 32 GAG GAt TCC TCT                                                TCA GA    47 GAG GAC                                                TCC TCT TCA GA    32                                                GAG GAC aCC TCT TCA                                                GA  42 GAG GAt TCC TCT TCA GAC   52 GAG GAC TCC TCT TCA GAC   42 GAG GAC                                                aCC TCT TCA GAC                                                 52 GAG GAt TCC TCT                                                TCA GAC G 60 GAG GAC                                                TCC TCT TCA GAC G 52                                                GAG GAC aCC TCT TCA                                                GAC G  42 .AG GAt TCC TCT TCA GAC G 52 .AG GAC TCC TCT TCA GAC G 42 .AG GAC                                                aCC TCT TCA GAC G                                                 42 ..G GAt TCC TCT                                                TCA GAC G 52 ..G GAC                                                TCC TCT TCA GAC G 42                                                ..G GAC aCC TCT TCA                                                GAC G  37 ... GAt TCC TCT TCA GAC G 47 ... GAC TCC TCT TCA GAC G 37 ... GAC                                                aCC TCT TCA GAC G                                                 32 ... .At TCC TCT                                                TCA GAC G 42 ... .AC                                                TCC TCT TCA GAC G 32                                                ... .AC aCC TCT TCA                                                GAC G  32 ... ..t TCC TCT TCA GAC G 42 ... ..C TCC TCT TCA GAC G 32 ... ..C                                                aCC TCT TCA GAC G                                                 32 ... ... TCC TCT                                                TCA GAC G 32 ... ...                                                TCC TCT TCA GAC G 32                                                ... ... aCC TCT TCA                                                GAC G__________________________________________________________________________</pre>
    
    <p>Between the three columns of array (b) listed above, were two columns, in which bases 6 and 7 from the left were missing in every line. These sequences all melted at 20 or 32 degrees, (a,t) mismatch base (.) missing base.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4216245">US4216245</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 25, 1978</td><td class="patent-data-table-td patent-date-value">Aug 5, 1980</td><td class="patent-data-table-td ">Miles Laboratories, Inc.</td><td class="patent-data-table-td ">Method of making printed reagent test devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4327073">US4327073</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 7, 1980</td><td class="patent-data-table-td patent-date-value">Apr 27, 1982</td><td class="patent-data-table-td ">Huang Henry V</td><td class="patent-data-table-td ">Automated method for quantitative analysis of biological fluids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4395486">US4395486</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 19, 1981</td><td class="patent-data-table-td patent-date-value">Jul 26, 1983</td><td class="patent-data-table-td ">Medical College Of Ga. Research Inst., Inc.</td><td class="patent-data-table-td ">Preferential fragmentation of deoxyribonucleic acid found in amniotic fluid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4563419">US4563419</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 29, 1983</td><td class="patent-data-table-td patent-date-value">Jan 7, 1986</td><td class="patent-data-table-td ">Orion Corporation Ltd.</td><td class="patent-data-table-td ">Detection of microbial nucleic acids by a one-step sandwich hybridization test</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4656127">US4656127</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 23, 1984</td><td class="patent-data-table-td patent-date-value">Apr 7, 1987</td><td class="patent-data-table-td ">Amersham International Plc.</td><td class="patent-data-table-td ">Method of detecting mutations in DNA and RNA</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4704353">US4704353</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 27, 1984</td><td class="patent-data-table-td patent-date-value">Nov 3, 1987</td><td class="patent-data-table-td ">Molecular Devices Corporation</td><td class="patent-data-table-td ">Photoresponsive redox detection and discrimination</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4728502">US4728502</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 26, 1985</td><td class="patent-data-table-td patent-date-value">Mar 1, 1988</td><td class="patent-data-table-td ">Hamill Brendan J</td><td class="patent-data-table-td ">Apparatus for the chemical synthesis of oligonucleotides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4888278">US4888278</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 13, 1988</td><td class="patent-data-table-td patent-date-value">Dec 19, 1989</td><td class="patent-data-table-td ">University Of Massachusetts Medical Center</td><td class="patent-data-table-td ">Contacting with non-homopolymer labelled probe of nucleic acid fragments</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4994373">US4994373</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 20, 1989</td><td class="patent-data-table-td patent-date-value">Feb 19, 1991</td><td class="patent-data-table-td ">Enzo Biochem, Inc.</td><td class="patent-data-table-td ">Method and structures employing chemically-labelled polynucleotide probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5002867">US5002867</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 24, 1988</td><td class="patent-data-table-td patent-date-value">Mar 26, 1991</td><td class="patent-data-table-td ">Macevicz Stephen C</td><td class="patent-data-table-td ">Nucleic acid sequence determination by multiple mixed oligonucleotide probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5164319">US5164319</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 17, 1989</td><td class="patent-data-table-td patent-date-value">Nov 17, 1992</td><td class="patent-data-table-td ">Molecular Devices Corporation</td><td class="patent-data-table-td ">Multiple chemically modulated capacitance determination</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5202231">US5202231</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 18, 1991</td><td class="patent-data-table-td patent-date-value">Apr 13, 1993</td><td class="patent-data-table-td ">Drmanac Radoje T</td><td class="patent-data-table-td ">Detecting probes which are exactly complementary to part of nucleic acid fragment being analyzed, then computerized comparison for sequence determination</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5445934">US5445934</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 30, 1992</td><td class="patent-data-table-td patent-date-value">Aug 29, 1995</td><td class="patent-data-table-td ">Affymax Technologies N.V.</td><td class="patent-data-table-td ">Selective photoremovable groups on surface</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5527681">US5527681</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 5, 1992</td><td class="patent-data-table-td patent-date-value">Jun 18, 1996</td><td class="patent-data-table-td ">Affymax Technologies N.V.</td><td class="patent-data-table-td ">Immobilized molecular synthesis of systematically substituted compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5677195">US5677195</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 20, 1992</td><td class="patent-data-table-td patent-date-value">Oct 14, 1997</td><td class="patent-data-table-td ">Affymax Technologies N.V.</td><td class="patent-data-table-td ">Forming oligonucleotides or peptides by forming flow channels in substrate surface, each of flow channels comprising walls which form fluid-tight seals with surface and a flow intake and outlet, flowing nucleic acids through channels to bind</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5700637">US5700637</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 19, 1994</td><td class="patent-data-table-td patent-date-value">Dec 23, 1997</td><td class="patent-data-table-td ">Isis Innovation Limited</td><td class="patent-data-table-td ">Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5744305">US5744305</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 6, 1995</td><td class="patent-data-table-td patent-date-value">Apr 28, 1998</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Arrays of materials attached to a substrate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5807522">US5807522</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">Sep 15, 1998</td><td class="patent-data-table-td ">The Board Of Trustees Of The Leland Stanford Junior University</td><td class="patent-data-table-td ">Tapping capillary dispenser on support with impulse to break meniscus; gene expression studies to diagnose disease</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5925525">US5925525</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 3, 1998</td><td class="patent-data-table-td patent-date-value">Jul 20, 1999</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Method of identifying nucleotide differences</td></tr><tr><td class="patent-data-table-td citation-patent"><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">CA1284931A</td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0063810A1?cl=en">EP0063810A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 26, 1982</td><td class="patent-data-table-td patent-date-value">Nov 3, 1982</td><td class="patent-data-table-td ">Ciba-Geigy Ag</td><td class="patent-data-table-td ">New devices and kits for immunological analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0130523A2?cl=en">EP0130523A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 25, 1984</td><td class="patent-data-table-td patent-date-value">Jan 9, 1985</td><td class="patent-data-table-td ">Molecular Diagnostics, Inc.</td><td class="patent-data-table-td ">Immobilized nucleic acid probe and solid support for nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0130739A2?cl=en">EP0130739A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 20, 1984</td><td class="patent-data-table-td patent-date-value">Jan 9, 1985</td><td class="patent-data-table-td ">Chiron Corporation</td><td class="patent-data-table-td ">Reactor system and method for polynucleotide synthesis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0142299A2?cl=en">EP0142299A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 23, 1984</td><td class="patent-data-table-td patent-date-value">May 22, 1985</td><td class="patent-data-table-td ">FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC.</td><td class="patent-data-table-td ">Method of measuring polynucleotide and reagent kit for use therein</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0171150B1?cl=en">EP0171150B1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 12, 1985</td><td class="patent-data-table-td patent-date-value">Mar 25, 1992</td><td class="patent-data-table-td ">Orgenics Ltd.</td><td class="patent-data-table-td ">Method and apparatus for assaying with optional reagent quality control</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0194132A2?cl=en">EP0194132A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 4, 1986</td><td class="patent-data-table-td patent-date-value">Sep 10, 1986</td><td class="patent-data-table-td ">Murex Corporation</td><td class="patent-data-table-td ">Imaging immunoassay detection system and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0228075A2?cl=en">EP0228075A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 23, 1986</td><td class="patent-data-table-td patent-date-value">Jul 8, 1987</td><td class="patent-data-table-td ">Molecular Diagnostics, Inc.</td><td class="patent-data-table-td ">Eucaryotic genomic dna dot-blot hybridization method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0235726A2?cl=en">EP0235726A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 24, 1987</td><td class="patent-data-table-td patent-date-value">Sep 9, 1987</td><td class="patent-data-table-td ">Miles Inc.</td><td class="patent-data-table-td ">Rapid detection of nucleic acid sequences in a sample by labeling the sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0237362A1?cl=en">EP0237362A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 13, 1987</td><td class="patent-data-table-td patent-date-value">Sep 16, 1987</td><td class="patent-data-table-td ">F. Hoffmann-La Roche Ag</td><td class="patent-data-table-td ">Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids and kits therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0238332A2?cl=en">EP0238332A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 18, 1987</td><td class="patent-data-table-td patent-date-value">Sep 23, 1987</td><td class="patent-data-table-td ">Cetus Corporation</td><td class="patent-data-table-td ">Liquid hybridization method and kit for detecting the presence of nucleic acid sequences in samples</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0268237A2?cl=en">EP0268237A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 16, 1987</td><td class="patent-data-table-td patent-date-value">May 25, 1988</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Apparatus and process for reagent fluid dispensing and printing</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0281927A2?cl=en">EP0281927A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 3, 1988</td><td class="patent-data-table-td patent-date-value">Sep 14, 1988</td><td class="patent-data-table-td ">Bayer Corporation</td><td class="patent-data-table-td ">Assay for nucleic acid sequences in a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0392546A2?cl=en">EP0392546A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 12, 1990</td><td class="patent-data-table-td patent-date-value">Oct 17, 1990</td><td class="patent-data-table-td ">Ro Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo</td><td class="patent-data-table-td ">Process for determination of a complete or a partial contents of very short sequences in the samples of nucleic acids connected to the discrete particles of microscopic size by hybridization with oligonucleotide probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=y-xOBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DGB%26NR%3D2156074A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNFZ7lv8xra4UAwZEMlfRcmk2YGbQA">GB2156074A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1984003151A1?cl=en">WO1984003151A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 2, 1984</td><td class="patent-data-table-td patent-date-value">Aug 16, 1984</td><td class="patent-data-table-td ">Centocor Inc</td><td class="patent-data-table-td ">Matrix of antibody-coated spots for determination of antigens</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1984003564A1?cl=en">WO1984003564A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 8, 1984</td><td class="patent-data-table-td patent-date-value">Sep 13, 1984</td><td class="patent-data-table-td ">Commw Serum Lab Commission</td><td class="patent-data-table-td ">Method of determining antigenically active amino acid sequences</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1985001051A1?cl=en">WO1985001051A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 21, 1984</td><td class="patent-data-table-td patent-date-value">Mar 14, 1985</td><td class="patent-data-table-td ">Molecular Biosystems Inc</td><td class="patent-data-table-td ">Oligonucleotide polymeric support system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1986000991A1?cl=en">WO1986000991A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 23, 1985</td><td class="patent-data-table-td patent-date-value">Feb 13, 1986</td><td class="patent-data-table-td ">Commw Serum Lab Commission</td><td class="patent-data-table-td ">Method for determining mimotopes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1986003782A1?cl=en">WO1986003782A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 19, 1985</td><td class="patent-data-table-td patent-date-value">Jul 3, 1986</td><td class="patent-data-table-td ">Blair Malcolm A D</td><td class="patent-data-table-td ">Improved sandwich hybridisation technique for the detection of nucleotide sequences</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1986006487A1?cl=en">WO1986006487A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 22, 1986</td><td class="patent-data-table-td patent-date-value">Nov 6, 1986</td><td class="patent-data-table-td ">Commw Serum Lab Commission</td><td class="patent-data-table-td ">Method for determining mimotopes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1988001302A1?cl=en">WO1988001302A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 11, 1987</td><td class="patent-data-table-td patent-date-value">Feb 25, 1988</td><td class="patent-data-table-td ">Siska Diagnostics Inc</td><td class="patent-data-table-td ">Nucleic acid probe assay methods and compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1989011548A1?cl=en">WO1989011548A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 18, 1989</td><td class="patent-data-table-td patent-date-value">Nov 30, 1989</td><td class="patent-data-table-td ">Cetus Corp</td><td class="patent-data-table-td ">Immobilized sequence-specific probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1993022480A1?cl=en">WO1993022480A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 23, 1993</td><td class="patent-data-table-td patent-date-value">Nov 11, 1993</td><td class="patent-data-table-td ">Isis Innovation</td><td class="patent-data-table-td ">Electrochemical treatment of surfaces</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">(Sep. 1988).</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">A. Palva et al., DNA, 7(2), 135 142 (1988).</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">A. Palva et al., DNA, 7(2), 135-142 (1988).</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">A. Rosenthal, Nucleic Acids Research, 13(4), 1173 1184 (1985).</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">A. Rosenthal, Nucleic Acids Research, 13(4), 1173-1184 (1985).</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">A.R. Brautigam et al., J. Clin. Microbiol., 12(2), 226 234 (1980).</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">A.R. Brautigam et al., J. Clin. Microbiol., 12(2), 226-234 (1980).</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">A.R. Dunn et al., Cell, 12, 23 26 (1977).</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">A.R. Dunn et al., Cell, 12, 23-26 (1977).</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">B. Lewin, Genes, 3rd Ed., John Wiley &amp; Sons, pp. 360 362 (1983).</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">B. Lewin, Genes, 3rd Ed., John Wiley &amp; Sons, pp. 360-362 (1983).</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Brigati et al., Virology, vol. 126, pp. 32 50, 1983.</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brigati et al., Virology, vol. 126, pp. 32-50, 1983.</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Bunemann et al. Nucleic Acids Research, 10(22), 7163 7180 (1982).</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bunemann et al. Nucleic Acids Research, 10(22), 7163-7180 (1982).</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Bunemann Nucleic Acids Research, 10(22), 7181 7196 (1982).</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bunemann Nucleic Acids Research, 10(22), 7181-7196 (1982).</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">C.G. Miyada et al., Methods in Enzymology, 154, 94 107 (1987).</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">C.G. Miyada et al., Methods in Enzymology, 154, 94-107 (1987).</td></tr><tr><td class="patent-data-table-td ">20</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">C.R. Cantor et al., Genomics, 13, 1378 1383 (1992).</td></tr><tr><td class="patent-data-table-td ">21</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">C.R. Cantor et al., Genomics, 13, 1378-1383 (1992).</td></tr><tr><td class="patent-data-table-td ">22</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Church et al., Science, 240, 185 188 (Apr. 8, 1988).</td></tr><tr><td class="patent-data-table-td ">23</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Church et al., Science, 240, 185-188 (Apr. 8, 1988).</td></tr><tr><td class="patent-data-table-td ">24</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Dean et al., Journal of Clinical Microbiology, 27(5), 1062 1067 (May 1989).</td></tr><tr><td class="patent-data-table-td ">25</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Dean et al., Journal of Clinical Microbiology, 27(5), 1062-1067 (May 1989).</td></tr><tr><td class="patent-data-table-td ">26</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">E. Calva et al., J. Biol. Chem., 255(22), 11011 11016 (1980).</td></tr><tr><td class="patent-data-table-td ">27</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">E. Calva et al., J. Biol. Chem., 255(22), 11011-11016 (1980).</td></tr><tr><td class="patent-data-table-td ">28</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">E.M. Southern et al., Genomics, 13, 1008 1017 (1992).</td></tr><tr><td class="patent-data-table-td ">29</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">E.M. Southern et al., Genomics, 13, 1008-1017 (1992).</td></tr><tr><td class="patent-data-table-td ">30</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ezaki et al., Cancer, 61, 106 109 (1988).</td></tr><tr><td class="patent-data-table-td ">31</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ezaki et al., Cancer, 61, 106-109 (1988).</td></tr><tr><td class="patent-data-table-td ">32</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ezaki et al., FEMS Microbiology Letters, 67, 127 130 (1990).</td></tr><tr><td class="patent-data-table-td ">33</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ezaki et al., FEMS Microbiology Letters, 67, 127-130 (1990).</td></tr><tr><td class="patent-data-table-td ">34</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ezaki et al., International Journal of Systematic Bacteriology, 36(2), 345 347 (1986).</td></tr><tr><td class="patent-data-table-td ">35</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ezaki et al., International Journal of Systematic Bacteriology, 36(2), 345-347 (1986).</td></tr><tr><td class="patent-data-table-td ">36</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ezaki et al., J. Gen. Appl. Microbiol., 34, 191 199 (1988).</td></tr><tr><td class="patent-data-table-td ">37</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ezaki et al., J. Gen. Appl. Microbiol., 34, 191-199 (1988).</td></tr><tr><td class="patent-data-table-td ">38</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ezaki et al., Journal of Clinical Microbiology, 26(9), 1708 1713</td></tr><tr><td class="patent-data-table-td ">39</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ezaki et al., Journal of Clinical Microbiology, 26(9), 1708-1713</td></tr><tr><td class="patent-data-table-td ">40</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ezaki et al., Microbiol. Immunol., 32(2), 141 150 (1988).</td></tr><tr><td class="patent-data-table-td ">41</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ezaki et al., Microbiol. Immunol., 32(2), 141-150 (1988).</td></tr><tr><td class="patent-data-table-td ">42</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ezaki, Asian Med. J., 34(8), 454 459 (1991).</td></tr><tr><td class="patent-data-table-td ">43</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ezaki, Asian Med. J., 34(8), 454-459 (1991).</td></tr><tr><td class="patent-data-table-td ">44</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">F. Kafatos et al., Nucleic Acids Research, 7(6), 1541 1552 (1979).</td></tr><tr><td class="patent-data-table-td ">45</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">F. Kafatos et al., Nucleic Acids Research, 7(6), 1541-1552 (1979).</td></tr><tr><td class="patent-data-table-td ">46</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Farrow et al., System. Appl. Microbiol., 5, 467 482 (1984).</td></tr><tr><td class="patent-data-table-td ">47</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Farrow et al., System. Appl. Microbiol., 5, 467-482 (1984).</td></tr><tr><td class="patent-data-table-td ">48</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Fodor et al., Science, vol. 251, pp. 767 773, 1991.</td></tr><tr><td class="patent-data-table-td ">49</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Fodor et al., Science, vol. 251, pp. 767-773, 1991.</td></tr><tr><td class="patent-data-table-td ">50</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Forster et al. Nucleic Acids Research, 13(3), 745 761 (1985).</td></tr><tr><td class="patent-data-table-td ">51</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Forster et al. Nucleic Acids Research, 13(3), 745-761 (1985).</td></tr><tr><td class="patent-data-table-td ">52</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Frankel et al., The Journal of Infectious Diseases, 161 1252 1256 (1990).</td></tr><tr><td class="patent-data-table-td ">53</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Frankel et al., The Journal of Infectious Diseases, 161 1252-1256 (1990).</td></tr><tr><td class="patent-data-table-td ">54</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">G. Beltz et al., Methods in Enzymology, 100, 266 285 (1983).</td></tr><tr><td class="patent-data-table-td ">55</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">G. Beltz et al., Methods in Enzymology, 100, 266-285 (1983).</td></tr><tr><td class="patent-data-table-td ">56</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">G. Wengler et al., Virology, 78, 124 134 (1977).</td></tr><tr><td class="patent-data-table-td ">57</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">G. Wengler et al., Virology, 78, 124-134 (1977).</td></tr><tr><td class="patent-data-table-td ">58</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">G.K. Sim et al., Cell, 18, 1303 1316 (1979).</td></tr><tr><td class="patent-data-table-td ">59</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">G.K. Sim et al., Cell, 18, 1303-1316 (1979).</td></tr><tr><td class="patent-data-table-td ">60</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">G.M. Church et al., Proc. Natl. Acad. Sci. USA, 81, 1991 1995 (1984).</td></tr><tr><td class="patent-data-table-td ">61</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">G.M. Church et al., Proc. Natl. Acad. Sci. USA, 81, 1991-1995 (1984).</td></tr><tr><td class="patent-data-table-td ">62</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ghosh et al. Farrow et al., System. Appl. Microbiol., 5, 483 493 (1984).</td></tr><tr><td class="patent-data-table-td ">63</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ghosh et al. Farrow et al., System. Appl. Microbiol., 5, 483-493 (1984).</td></tr><tr><td class="patent-data-table-td ">64</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Gingeras et al. Nucleic Acids Research, 15(13), 5373 5390 (1987).</td></tr><tr><td class="patent-data-table-td ">65</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gingeras et al. Nucleic Acids Research, 15(13), 5373-5390 (1987).</td></tr><tr><td class="patent-data-table-td ">66</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gingeras, T.R., et al., "<a href='http://scholar.google.com/scholar?q="Nucleic+Acids+Research"'>Nucleic Acids Research</a>", 15(13), 5373-5390 (1987).</td></tr><tr><td class="patent-data-table-td ">67</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Gingeras, T.R., et al., Nucleic Acids Research , 15(13), 5373 5390 (1987).</td></tr><tr><td class="patent-data-table-td ">68</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Gingeres et al., Nucleic Acids Research, vol. 15, No. 13, pp. 5373 5390 (1987).</td></tr><tr><td class="patent-data-table-td ">69</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gingeres et al., Nucleic Acids Research, vol. 15, No. 13, pp. 5373-5390 (1987).</td></tr><tr><td class="patent-data-table-td ">70</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Graham et al., Gene, vol. 48, pp. 241 249, 1986.</td></tr><tr><td class="patent-data-table-td ">71</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Graham et al., Gene, vol. 48, pp. 241-249, 1986.</td></tr><tr><td class="patent-data-table-td ">72</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">H.M. Geysen et al., J. Immun. Meth., 102, 259 274 (1987).</td></tr><tr><td class="patent-data-table-td ">73</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">H.M. Geysen et al., J. Immun. Meth., 102, 259-274 (1987).</td></tr><tr><td class="patent-data-table-td ">74</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Habermehl, Ed., Rapid Methods and Automation in Microbiology and Immunology, 30 33 (1985).</td></tr><tr><td class="patent-data-table-td ">75</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Habermehl, Ed., Rapid Methods and Automation in Microbiology and Immunology, 30-33 (1985).</td></tr><tr><td class="patent-data-table-td ">76</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">J.M. Coffin et al., Cell, 13, 761 773 (1978).</td></tr><tr><td class="patent-data-table-td ">77</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">J.M. Coffin et al., Cell, 13, 761-773 (1978).</td></tr><tr><td class="patent-data-table-td ">78</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Kilpper Balz et al., System. Appl. Microbiol., 5, 494 500 (1984).</td></tr><tr><td class="patent-data-table-td ">79</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kilpper-Balz et al., System. Appl. Microbiol., 5, 494-500 (1984).</td></tr><tr><td class="patent-data-table-td ">80</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Koomey et al., Infection and Immunity, 43(1), 101 107 (Jan. 1984).</td></tr><tr><td class="patent-data-table-td ">81</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Koomey et al., Infection and Immunity, 43(1), 101-107 (Jan. 1984).</td></tr><tr><td class="patent-data-table-td ">82</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">L.J. Arnold et al., Federation Proceedings, 43(7), Abstract No. 3669 (1984).</td></tr><tr><td class="patent-data-table-td ">83</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">M. Anderson et al., Nucleic Acid Hybridisation, A Practical Approach, B.D. Hames et al., IRL Press, pp. 73 111 (1985).</td></tr><tr><td class="patent-data-table-td ">84</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">M. Anderson et al., Nucleic Acid Hybridisation, A Practical Approach, B.D. Hames et al., IRL Press, pp. 73-111 (1985).</td></tr><tr><td class="patent-data-table-td ">85</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">M.S. Urdea et al., Gene, 61, 253 264 (1987).</td></tr><tr><td class="patent-data-table-td ">86</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">M.S. Urdea et al., Gene, 61, 253-264 (1987).</td></tr><tr><td class="patent-data-table-td ">87</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">McDonough et al., Journal of Clinical Microbiology, 26(12), 2515 2519 (1988).</td></tr><tr><td class="patent-data-table-td ">88</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">McDonough et al., Journal of Clinical Microbiology, 26(12), 2515-2519 (1988).</td></tr><tr><td class="patent-data-table-td ">89</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Moseley et al., Advances in Research on Cholera and Related Diarrheas, 207 216 (1983).</td></tr><tr><td class="patent-data-table-td ">90</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Moseley et al., Advances in Research on Cholera and Related Diarrheas, 207-216 (1983).</td></tr><tr><td class="patent-data-table-td ">91</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Nagata et al., FEBS Letters, 183(2), 379 382 (Apr. 1985).</td></tr><tr><td class="patent-data-table-td ">92</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Nagata et al., FEBS Letters, 183(2), 379-382 (Apr. 1985).</td></tr><tr><td class="patent-data-table-td ">93</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Nucleic Acids Research, 15(13), 5353 5372 (1987).</td></tr><tr><td class="patent-data-table-td ">94</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Nucleic Acids Research, 15(13), 5353-5372 (1987).</td></tr><tr><td class="patent-data-table-td ">95</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ogle et al., The Journal of Infectious Diseases, 155(1), 119 126 (Jan. 1987).</td></tr><tr><td class="patent-data-table-td ">96</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ogle et al., The Journal of Infectious Diseases, 155(1), 119-126 (Jan. 1987).</td></tr><tr><td class="patent-data-table-td ">97</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">P. Masinkoswki et al., Nucleic Acids Research, 10(24), 7895 7903 (1982).</td></tr><tr><td class="patent-data-table-td ">98</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">P. Masinkoswki et al., Nucleic Acids Research, 10(24), 7895-7903 (1982).</td></tr><tr><td class="patent-data-table-td ">99</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Potter et al., Gene, vol. 48, pp. 229 239, 1986.</td></tr><tr><td class="patent-data-table-td ">100</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Potter et al., Gene, vol. 48, pp. 229-239, 1986.</td></tr><tr><td class="patent-data-table-td ">101</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">R. Drmanac et al., "<a href='http://scholar.google.com/scholar?q="Sequencing+of+Megabase+Plus+DNA+by+Hybridization%3A+Theory+of+the+Method"'>Sequencing of Megabase Plus DNA by Hybridization: Theory of the Method</a>", University of Belgrade (former Yugoslavia) (1988).</td></tr><tr><td class="patent-data-table-td ">102</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">R. Drmanac et al., Sequencing of Megabase Plus DNA by Hybridization: Theory of the Method , University of Belgrade (former Yugoslavia) (1988).</td></tr><tr><td class="patent-data-table-td ">103</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">R. Frank, Methods in Enzymology , 154, 221 251 (1987).</td></tr><tr><td class="patent-data-table-td ">104</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">R. Frank, Methods in Enzymology, 154, 221-251 (1987).</td></tr><tr><td class="patent-data-table-td ">105</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">R. Frank, Nucleic Acids Research, 11(13), 4365 4377 (1983).</td></tr><tr><td class="patent-data-table-td ">106</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">R. Frank, Nucleic Acids Research, 11(13), 4365-4377 (1983).</td></tr><tr><td class="patent-data-table-td ">107</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">R.K. Saiki et al., Nature, 324, 163 166 (1986).</td></tr><tr><td class="patent-data-table-td ">108</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">R.K. Saiki et al., Nature, 324, 163-166 (1986).</td></tr><tr><td class="patent-data-table-td ">109</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Robins Browne et al., Journal of Clinical Microbiology, 27(4), 644 650 (Apr. 1989).</td></tr><tr><td class="patent-data-table-td ">110</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Robins-Browne et al., Journal of Clinical Microbiology, 27(4), 644-650 (Apr. 1989).</td></tr><tr><td class="patent-data-table-td ">111</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Saiki et al., Nature, vol. 324, pp. 163 166, 1986.</td></tr><tr><td class="patent-data-table-td ">112</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Saiki et al., Nature, vol. 324, pp. 163-166, 1986.</td></tr><tr><td class="patent-data-table-td ">113</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Schachter, Diagn. Microbiol. Infect. Dis., 4, 185 189 (1986).</td></tr><tr><td class="patent-data-table-td ">114</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Schachter, Diagn. Microbiol. Infect. Dis., 4, 185-189 (1986).</td></tr><tr><td class="patent-data-table-td ">115</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Starnbach, Journal of Clinical Microbiology, 27(6), 1257 1261 (Jun. 1989).</td></tr><tr><td class="patent-data-table-td ">116</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Starnbach, Journal of Clinical Microbiology, 27(6), 1257-1261 (Jun. 1989).</td></tr><tr><td class="patent-data-table-td ">117</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Syvanen, Medical Biology, 64, 313 324 (1986) (Review Article).</td></tr><tr><td class="patent-data-table-td ">118</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Syvanen, Medical Biology, 64, 313-324 (1986) (Review Article).</td></tr><tr><td class="patent-data-table-td ">119</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">T. Maniatis et al., Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory, p. 282 (1982).</td></tr><tr><td class="patent-data-table-td ">120</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Tenover, Clinical Microbiology Reviews, 1(1), 82 101 (Jan. 1988).</td></tr><tr><td class="patent-data-table-td ">121</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Tenover, Clinical Microbiology Reviews, 1(1), 82-101 (Jan. 1988).</td></tr><tr><td class="patent-data-table-td ">122</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">U.B. Voss et al., Biochemical Society Transactions, 624th Meeting, Dublin, 216 217 (1987).</td></tr><tr><td class="patent-data-table-td ">123</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">U.B. Voss et al., Biochemical Society Transactions, 624th Meeting, Dublin, 216-217 (1987).</td></tr><tr><td class="patent-data-table-td ">124</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">V.J. Kidd et al., Nature, 304, 230 234 (1983).</td></tr><tr><td class="patent-data-table-td ">125</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">V.J. Kidd et al., Nature, 304, 230-234 (1983).</td></tr><tr><td class="patent-data-table-td ">126</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">W. Bains et al., J. Theor. Biol., 135, 303 307 (1988).</td></tr><tr><td class="patent-data-table-td ">127</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">W. Bains et al., J. Theor. Biol., 135, 303-307 (1988).</td></tr><tr><td class="patent-data-table-td ">128</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Wood et al., Proc. Natl. Acad. Sci. (USA), vol. 82, pp. 1585 1588, 1985.</td></tr><tr><td class="patent-data-table-td ">129</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Wood et al., Proc. Natl. Acad. Sci. (USA), vol. 82, pp. 1585-1588, 1985.</td></tr><tr><td class="patent-data-table-td ">130</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Y.P. Lysov et al., Dokl. Akad., 303, 1508 1511 (1988) (with English translation).</td></tr><tr><td class="patent-data-table-td ">131</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Y.P. Lysov et al., Dokl. Akad., 303, 1508-1511 (1988) (with English translation).</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6225625">US6225625</a></td><td class="patent-data-table-td patent-date-value">Jun 1, 1995</td><td class="patent-data-table-td patent-date-value">May 1, 2001</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Signal detection methods and apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6329140">US6329140</a></td><td class="patent-data-table-td patent-date-value">Sep 18, 1997</td><td class="patent-data-table-td patent-date-value">Dec 11, 2001</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Screening clones on a support that is a high-density nucleic acid array by analyzing hybridization of a target nucleic acid with differently sequenced polynucleotide probes using various stringency conditions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6376191">US6376191</a></td><td class="patent-data-table-td patent-date-value">Nov 6, 2000</td><td class="patent-data-table-td patent-date-value">Apr 23, 2002</td><td class="patent-data-table-td ">Mergen, Ltd.</td><td class="patent-data-table-td ">Microarray-based analysis of polynucleotide sequence variations</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6391550">US6391550</a></td><td class="patent-data-table-td patent-date-value">May 27, 1999</td><td class="patent-data-table-td patent-date-value">May 21, 2002</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Identification of molecular sequence signatures and methods involving the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6391622">US6391622</a></td><td class="patent-data-table-td patent-date-value">Jun 27, 2000</td><td class="patent-data-table-td patent-date-value">May 21, 2002</td><td class="patent-data-table-td ">Caliper Technologies Corp.</td><td class="patent-data-table-td ">Closed-loop biochemical analyzers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6403338">US6403338</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 27, 2000</td><td class="patent-data-table-td patent-date-value">Jun 11, 2002</td><td class="patent-data-table-td ">Mountain View</td><td class="patent-data-table-td ">Fluid flowing sample containing nucleic acid into microscale chamber; amplification of plurality of sequences; detecting polymorphisms; dna sequencing</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6406893">US6406893</a></td><td class="patent-data-table-td patent-date-value">Nov 20, 2000</td><td class="patent-data-table-td patent-date-value">Jun 18, 2002</td><td class="patent-data-table-td ">Caliper Technologies Corp.</td><td class="patent-data-table-td ">Amplification of target nucleic acid, channels</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6440722">US6440722</a></td><td class="patent-data-table-td patent-date-value">Jun 27, 2000</td><td class="patent-data-table-td patent-date-value">Aug 27, 2002</td><td class="patent-data-table-td ">Caliper Technologies Corp.</td><td class="patent-data-table-td ">Microfluidic devices and methods for optimizing reactions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6444461">US6444461</a></td><td class="patent-data-table-td patent-date-value">Sep 20, 2000</td><td class="patent-data-table-td patent-date-value">Sep 3, 2002</td><td class="patent-data-table-td ">Caliper Technologies Corp.</td><td class="patent-data-table-td ">Microfluidic devices and methods for separation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6458530">US6458530</a></td><td class="patent-data-table-td patent-date-value">Apr 4, 1996</td><td class="patent-data-table-td patent-date-value">Oct 1, 2002</td><td class="patent-data-table-td ">Affymetrix Inc.</td><td class="patent-data-table-td ">Selecting tag nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6500620">US6500620</a></td><td class="patent-data-table-td patent-date-value">Dec 19, 2000</td><td class="patent-data-table-td patent-date-value">Dec 31, 2002</td><td class="patent-data-table-td ">Mergen Ltd.</td><td class="patent-data-table-td ">Methods for amplifying and detecting multiple polynucleotides on a solid phase support</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6566071">US6566071</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 2, 2001</td><td class="patent-data-table-td patent-date-value">May 20, 2003</td><td class="patent-data-table-td ">Applera Corporation</td><td class="patent-data-table-td ">Useful as fluorescent labeling reagents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6589726">US6589726</a></td><td class="patent-data-table-td patent-date-value">Aug 23, 2000</td><td class="patent-data-table-td patent-date-value">Jul 8, 2003</td><td class="patent-data-table-td ">Metrigen, Inc.</td><td class="patent-data-table-td ">Method and apparatus for in situ synthesis on a solid support</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6594432">US6594432</a></td><td class="patent-data-table-td patent-date-value">Feb 22, 2001</td><td class="patent-data-table-td patent-date-value">Jul 15, 2003</td><td class="patent-data-table-td ">Genospectra, Inc.</td><td class="patent-data-table-td ">Capillary bundles for use in the detection of preferential particle in sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6632641">US6632641</a></td><td class="patent-data-table-td patent-date-value">Oct 10, 2000</td><td class="patent-data-table-td patent-date-value">Oct 14, 2003</td><td class="patent-data-table-td ">Metrigen, Inc.</td><td class="patent-data-table-td ">Filling wells in solid supports with reactants; releasing polynucleotides into solution in wells; amplification</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6670133">US6670133</a></td><td class="patent-data-table-td patent-date-value">Jul 17, 2002</td><td class="patent-data-table-td patent-date-value">Dec 30, 2003</td><td class="patent-data-table-td ">Caliper Technologies Corp.</td><td class="patent-data-table-td ">Microfluidic device for sequencing by hybridization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6681186">US6681186</a></td><td class="patent-data-table-td patent-date-value">Sep 8, 2000</td><td class="patent-data-table-td patent-date-value">Jan 20, 2004</td><td class="patent-data-table-td ">Paracel, Inc.</td><td class="patent-data-table-td ">Data processing, computers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6692914">US6692914</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2000</td><td class="patent-data-table-td patent-date-value">Feb 17, 2004</td><td class="patent-data-table-td ">Symyx Technologies, Inc.</td><td class="patent-data-table-td ">Polymer brush that features a polymer layer on a substrate surface</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6731781">US6731781</a></td><td class="patent-data-table-td patent-date-value">Oct 12, 1999</td><td class="patent-data-table-td patent-date-value">May 4, 2004</td><td class="patent-data-table-td ">Biodiscovery, Inc.</td><td class="patent-data-table-td ">System and method for automatically processing microarrays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6753141">US6753141</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 25, 2001</td><td class="patent-data-table-td patent-date-value">Jun 22, 2004</td><td class="patent-data-table-td ">The University Of Utah</td><td class="patent-data-table-td ">Detection of nucleotide sequence mutation; obtain nucleotide sequence sample, denature and determine melting temperature, evaluate probe hybridization pattern</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6808934">US6808934</a></td><td class="patent-data-table-td patent-date-value">Jan 22, 2002</td><td class="patent-data-table-td patent-date-value">Oct 26, 2004</td><td class="patent-data-table-td ">Picoliter Inc.</td><td class="patent-data-table-td ">Comprises acoustic ejection of fluid droplets from reservoirs to form arrays; for preparing combinatorial libraries for proteins</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6824740">US6824740</a></td><td class="patent-data-table-td patent-date-value">Apr 28, 2000</td><td class="patent-data-table-td patent-date-value">Nov 30, 2004</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Single system for complete dna diagnostic assay; capable of cell selection, purification, concentration, buffer exchange, denaturization, complexity reduction, analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6833276">US6833276</a></td><td class="patent-data-table-td patent-date-value">Jul 24, 2001</td><td class="patent-data-table-td patent-date-value">Dec 21, 2004</td><td class="patent-data-table-td ">Symyx Technologies, Inc.</td><td class="patent-data-table-td ">Detectors for quantative, qualitative analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6838053">US6838053</a></td><td class="patent-data-table-td patent-date-value">Aug 3, 2001</td><td class="patent-data-table-td patent-date-value">Jan 4, 2005</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Electronically addressable microchip comprising electrode, permeation layer, linker moieties connecting electrode to permeation layer by covalent bonds capable of withstanding specified current density</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6838447">US6838447</a></td><td class="patent-data-table-td patent-date-value">Mar 26, 2002</td><td class="patent-data-table-td patent-date-value">Jan 4, 2005</td><td class="patent-data-table-td ">Linden Technologies, Inc.</td><td class="patent-data-table-td ">Immobilized nucleotide chargable particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6839454">US6839454</a></td><td class="patent-data-table-td patent-date-value">Oct 12, 1999</td><td class="patent-data-table-td patent-date-value">Jan 4, 2005</td><td class="patent-data-table-td ">Biodiscovery, Inc.</td><td class="patent-data-table-td ">System and method for automatically identifying sub-grids in a microarray</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6849411">US6849411</a></td><td class="patent-data-table-td patent-date-value">Nov 22, 2002</td><td class="patent-data-table-td patent-date-value">Feb 1, 2005</td><td class="patent-data-table-td ">Caliper Life Sciences, Inc.</td><td class="patent-data-table-td ">Microfluidic sequencing methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6852488">US6852488</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 6, 2001</td><td class="patent-data-table-td patent-date-value">Feb 8, 2005</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Identifying a base in a nucleic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6855501">US6855501</a></td><td class="patent-data-table-td patent-date-value">Mar 26, 2002</td><td class="patent-data-table-td patent-date-value">Feb 15, 2005</td><td class="patent-data-table-td ">Linden Technologies, Inc.</td><td class="patent-data-table-td ">Transfer of arrayed chemical compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6867048">US6867048</a></td><td class="patent-data-table-td patent-date-value">May 7, 2002</td><td class="patent-data-table-td patent-date-value">Mar 15, 2005</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Multiplexed active biologic array</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6887362">US6887362</a></td><td class="patent-data-table-td patent-date-value">Feb 6, 2002</td><td class="patent-data-table-td patent-date-value">May 3, 2005</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Medical diagnosis; applying high voltage pulses; determination positioning</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6902921">US6902921</a></td><td class="patent-data-table-td patent-date-value">May 23, 2002</td><td class="patent-data-table-td patent-date-value">Jun 7, 2005</td><td class="patent-data-table-td ">454 Corporation</td><td class="patent-data-table-td ">Genetically engineered adenosine triphosphate generating polypeptide; sequences determination; reporter molecules</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6921636">US6921636</a></td><td class="patent-data-table-td patent-date-value">Nov 16, 2000</td><td class="patent-data-table-td patent-date-value">Jul 26, 2005</td><td class="patent-data-table-td ">Metrigen, Inc.</td><td class="patent-data-table-td ">Method and apparatus for conducting an array of chemical reactions on a support surface</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6933117">US6933117</a></td><td class="patent-data-table-td patent-date-value">Apr 30, 2002</td><td class="patent-data-table-td patent-date-value">Aug 23, 2005</td><td class="patent-data-table-td ">Ventana Medical Systems, Inc.</td><td class="patent-data-table-td ">Composition for use in the automated medical and genetic analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6953551">US6953551</a></td><td class="patent-data-table-td patent-date-value">Feb 22, 2001</td><td class="patent-data-table-td patent-date-value">Oct 11, 2005</td><td class="patent-data-table-td ">Genospectra, Inc.</td><td class="patent-data-table-td ">Microarray fabrication techniques and apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6956114">US6956114</a></td><td class="patent-data-table-td patent-date-value">Apr 11, 2002</td><td class="patent-data-table-td patent-date-value">Oct 18, 2005</td><td class="patent-data-table-td ">&#39;454 Corporation</td><td class="patent-data-table-td ">Sulfurylase-luciferase fusion proteins and thermostable sulfurylase</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6960298">US6960298</a></td><td class="patent-data-table-td patent-date-value">Dec 10, 2001</td><td class="patent-data-table-td patent-date-value">Nov 1, 2005</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Mesoporous permeation layers for use on active electronic matrix devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6977178">US6977178</a></td><td class="patent-data-table-td patent-date-value">Sep 3, 2002</td><td class="patent-data-table-td patent-date-value">Dec 20, 2005</td><td class="patent-data-table-td ">Transnetyx, Inc.</td><td class="patent-data-table-td ">System and method for transgenic and targeted mutagenesis screening</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6989086">US6989086</a></td><td class="patent-data-table-td patent-date-value">Jul 13, 2001</td><td class="patent-data-table-td patent-date-value">Jan 24, 2006</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6990221">US6990221</a></td><td class="patent-data-table-td patent-date-value">Sep 10, 2003</td><td class="patent-data-table-td patent-date-value">Jan 24, 2006</td><td class="patent-data-table-td ">Biodiscovery, Inc.</td><td class="patent-data-table-td ">quantification of gene expression levels; storing the frame of information in memory, generating a grid of spaced grid points, quanitifying at least a portion of image; data quantification and extraction</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7011943">US7011943</a></td><td class="patent-data-table-td patent-date-value">Sep 4, 2001</td><td class="patent-data-table-td patent-date-value">Mar 14, 2006</td><td class="patent-data-table-td ">Transnetyx, Inc.</td><td class="patent-data-table-td ">Detecting preferential nucleotide sequences in pool of sequences; obtain nucleotide sequences, deposit on substrate, incubate with probe, detect signal, which indicates, presencec of preferential sequences</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7045097">US7045097</a></td><td class="patent-data-table-td patent-date-value">May 7, 2002</td><td class="patent-data-table-td patent-date-value">May 16, 2006</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Self- addressable, self-assembling microelectronic systems for carrying out and controlling multi-step and multiplex reactions in microscopic formats; for monitoring biological reactions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7049102">US7049102</a></td><td class="patent-data-table-td patent-date-value">Nov 15, 2000</td><td class="patent-data-table-td patent-date-value">May 23, 2006</td><td class="patent-data-table-td ">Board Of Trustees Of Leland Stanford University</td><td class="patent-data-table-td ">Multi-gene expression profile</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7056666">US7056666</a></td><td class="patent-data-table-td patent-date-value">Feb 14, 2002</td><td class="patent-data-table-td patent-date-value">Jun 6, 2006</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Analysis of surface immobilized polymers utilizing microfluorescence detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7060224">US7060224</a></td><td class="patent-data-table-td patent-date-value">Jan 6, 2003</td><td class="patent-data-table-td patent-date-value">Jun 13, 2006</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Methods for the electronic, homogeneous assembly and fabrication of devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7070961">US7070961</a></td><td class="patent-data-table-td patent-date-value">Oct 9, 2001</td><td class="patent-data-table-td patent-date-value">Jul 4, 2006</td><td class="patent-data-table-td ">Nanogen/Becton Dickinson Partnership</td><td class="patent-data-table-td ">Amplifying preferential target nucleic acids; obtain biochip, couple nucleotide sequences to chip, incubate with sample containing target nucleotide sequences, expose to primer, amplify and recover nucleotids sequences</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7099502">US7099502</a></td><td class="patent-data-table-td patent-date-value">Jan 21, 2004</td><td class="patent-data-table-td patent-date-value">Aug 29, 2006</td><td class="patent-data-table-td ">Biodiscovery, Inc.</td><td class="patent-data-table-td ">System and method for automatically processing microarrays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7101717">US7101717</a></td><td class="patent-data-table-td patent-date-value">Jan 23, 2004</td><td class="patent-data-table-td patent-date-value">Sep 5, 2006</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Precise voltage/current control; minimizes off chip circuitry; multistep and multiplex reactions in microscopic formats</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7135283">US7135283</a></td><td class="patent-data-table-td patent-date-value">Nov 17, 1998</td><td class="patent-data-table-td patent-date-value">Nov 14, 2006</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Topoisomerase type II gene polymorphisms and their use in identifying drug resistance and pathogenic strains of microorganisms</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7135285">US7135285</a></td><td class="patent-data-table-td patent-date-value">Mar 14, 2002</td><td class="patent-data-table-td patent-date-value">Nov 14, 2006</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Identification of molecular sequence signatures and methods involving the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7144699">US7144699</a></td><td class="patent-data-table-td patent-date-value">Mar 19, 1998</td><td class="patent-data-table-td patent-date-value">Dec 5, 2006</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Iterative resequencing</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7150997">US7150997</a></td><td class="patent-data-table-td patent-date-value">Mar 15, 2005</td><td class="patent-data-table-td patent-date-value">Dec 19, 2006</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Electrode array assembly formed on integrated circuit chip; includes row decoder, column decoder, counter coupled to decoders, matrix of active biologic electrodes, memory, and digital to analog converter; monitoring reactions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7172864">US7172864</a></td><td class="patent-data-table-td patent-date-value">Jan 24, 2000</td><td class="patent-data-table-td patent-date-value">Feb 6, 2007</td><td class="patent-data-table-td ">Nanogen</td><td class="patent-data-table-td ">Contacting biomolecule in solution with permeation layer at a microlocation;concentrating by placing electrode at an opposite charge; reacting restriction enzyme, ligase, proteinase, glycosidase, DNA or RNA polymerase or a phosphorylase with biomolecule; diagnosis; molecular hybridization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7195872">US7195872</a></td><td class="patent-data-table-td patent-date-value">Nov 8, 2002</td><td class="patent-data-table-td patent-date-value">Mar 27, 2007</td><td class="patent-data-table-td ">3D Biosurfaces, Inc.</td><td class="patent-data-table-td ">Comprises substrate containing coatings such as silica and titania and dopants such as lithium oxide and sodium oxide for use on surface of bioreactor; analysis/sequencing biopolymers; microfluidics</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7205161">US7205161</a></td><td class="patent-data-table-td patent-date-value">Jan 10, 2002</td><td class="patent-data-table-td patent-date-value">Apr 17, 2007</td><td class="patent-data-table-td ">Symyx Technologies, Inc.</td><td class="patent-data-table-td ">Polymer brushes for immobilizing molecules to a surface or substrate having improved stability</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7211390">US7211390</a></td><td class="patent-data-table-td patent-date-value">Feb 26, 2004</td><td class="patent-data-table-td patent-date-value">May 1, 2007</td><td class="patent-data-table-td ">454 Life Sciences Corporation</td><td class="patent-data-table-td ">Method of sequencing a nucleic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7214492">US7214492</a></td><td class="patent-data-table-td patent-date-value">Mar 3, 2005</td><td class="patent-data-table-td patent-date-value">May 8, 2007</td><td class="patent-data-table-td ">The University Of North Carolina At Greensboro</td><td class="patent-data-table-td ">Generating an array comprising a plurality of oligonucleotides immobilized at known locations on a substrate, preparing a nucleic acid sample from the ecosystem of interest;hybridizing the nucleic acid sample to the array;measuring hybridization of the nucleic acid sample to the array, correlating</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7217522">US7217522</a></td><td class="patent-data-table-td patent-date-value">Feb 10, 2005</td><td class="patent-data-table-td patent-date-value">May 15, 2007</td><td class="patent-data-table-td ">Campass Genetics Llc</td><td class="patent-data-table-td ">extending a primer annealed to polynucleotides having predetermined sequence characteristics to incorporate a predetermined terminator having a capture moiety; capturing; melting the captured polynucleotides from the extended primer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7238323">US7238323</a></td><td class="patent-data-table-td patent-date-value">Dec 5, 2002</td><td class="patent-data-table-td patent-date-value">Jul 3, 2007</td><td class="patent-data-table-td ">Caliper Life Sciences, Inc.</td><td class="patent-data-table-td ">Microfluidic sequencing systems</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7244559">US7244559</a></td><td class="patent-data-table-td patent-date-value">Mar 21, 2001</td><td class="patent-data-table-td patent-date-value">Jul 17, 2007</td><td class="patent-data-table-td ">454 Life Sciences Corporation</td><td class="patent-data-table-td ">Sequences determination of preferential nucleotide sequences; provide primers and nucleotide sequence patterns, mix, anneal primer to nucleotide sequences, mix nucleotides, determine sequence of sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7264929">US7264929</a></td><td class="patent-data-table-td patent-date-value">Nov 19, 2002</td><td class="patent-data-table-td patent-date-value">Sep 4, 2007</td><td class="patent-data-table-td ">454 Life Sciences Corporation</td><td class="patent-data-table-td ">Method of sequencing a nucleic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7267751">US7267751</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 2002</td><td class="patent-data-table-td patent-date-value">Sep 11, 2007</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Programmable multiplexed active biologic array</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7270850">US7270850</a></td><td class="patent-data-table-td patent-date-value">Mar 16, 2005</td><td class="patent-data-table-td patent-date-value">Sep 18, 2007</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Mesoporous permeation layers for use on active electronic matrix devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7282361">US7282361</a></td><td class="patent-data-table-td patent-date-value">Mar 8, 2005</td><td class="patent-data-table-td patent-date-value">Oct 16, 2007</td><td class="patent-data-table-td ">Transnetyx, Inc.</td><td class="patent-data-table-td ">Treating mammalian tissue with a lysis buffer of proteinase K to obtain a lysate, binding genomic DNA to magnetic particles in the presence of the lysate, and disassociating the DNA from the magnetic particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7300757">US7300757</a></td><td class="patent-data-table-td patent-date-value">Aug 23, 2004</td><td class="patent-data-table-td patent-date-value">Nov 27, 2007</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Electronic systems and component devices for macroscopic and microscopic molecular biological reaction, analyses, and diagnostics</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7314542">US7314542</a></td><td class="patent-data-table-td patent-date-value">Sep 22, 2005</td><td class="patent-data-table-td patent-date-value">Jan 1, 2008</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Methods and materials for optimization of electronic transportation and hybridization reactions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7314708">US7314708</a></td><td class="patent-data-table-td patent-date-value">Aug 4, 1998</td><td class="patent-data-table-td patent-date-value">Jan 1, 2008</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Electronically controlling the transport and attachment of specific binding entities to specific micro-locations in the synthesis of biopolymers such as DNA and polypeptides; producing a complement of a self-addressable electronic device addressed with specific DNA sequences</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7317820">US7317820</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2004</td><td class="patent-data-table-td patent-date-value">Jan 8, 2008</td><td class="patent-data-table-td ">Biodiscovery, Inc</td><td class="patent-data-table-td ">System and method for automatically identifying sub-grids in a microarray</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7323305">US7323305</a></td><td class="patent-data-table-td patent-date-value">Sep 22, 2004</td><td class="patent-data-table-td patent-date-value">Jan 29, 2008</td><td class="patent-data-table-td ">454 Life Sciences Corporation</td><td class="patent-data-table-td ">Determining sequence of preferential nucleotide sequences comprising, fragmenting large template nucleic, deliver to microreation chamber filled with water-in-oil emulsion, amplify and bind copies to beads, incubate with array and sequence</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7323307">US7323307</a></td><td class="patent-data-table-td patent-date-value">Aug 4, 2004</td><td class="patent-data-table-td patent-date-value">Jan 29, 2008</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Classifying messenger RNA sequences and identifying exon splice junctions for use in prediciting peptide binding domain and protein active site; protein engineering</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7335762">US7335762</a></td><td class="patent-data-table-td patent-date-value">Aug 15, 2002</td><td class="patent-data-table-td patent-date-value">Feb 26, 2008</td><td class="patent-data-table-td ">454 Life Sciences Corporation</td><td class="patent-data-table-td ">Cuvette for use in the concurrent monitoring, recording and analysis of lignt emission in microarrays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7341841">US7341841</a></td><td class="patent-data-table-td patent-date-value">Dec 16, 2005</td><td class="patent-data-table-td patent-date-value">Mar 11, 2008</td><td class="patent-data-table-td ">Accelr8 Technology Corporation</td><td class="patent-data-table-td ">Multicompartment electrophoretic apparatus for quantifying microorganisms in solution; drug screening and microbiocides; detection of microorganisms</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7365179">US7365179</a></td><td class="patent-data-table-td patent-date-value">Sep 2, 2004</td><td class="patent-data-table-td patent-date-value">Apr 29, 2008</td><td class="patent-data-table-td ">Compass Genetics, Llc</td><td class="patent-data-table-td ">Solid phase support for use in genomic analysis; gene expression analysis; high throughput assay; genotyping</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7407757">US7407757</a></td><td class="patent-data-table-td patent-date-value">Jun 30, 2005</td><td class="patent-data-table-td patent-date-value">Aug 5, 2008</td><td class="patent-data-table-td ">Population Genetics Technologies</td><td class="patent-data-table-td ">Genetic analysis by sequence-specific sorting</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7413852">US7413852</a></td><td class="patent-data-table-td patent-date-value">Dec 11, 2002</td><td class="patent-data-table-td patent-date-value">Aug 19, 2008</td><td class="patent-data-table-td ">High Throughput Genomics</td><td class="patent-data-table-td ">Multicompartment apparatus for detection, quantification and sequence determination of one or more molecular structures; high throughput assay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7463358">US7463358</a></td><td class="patent-data-table-td patent-date-value">Dec 6, 2005</td><td class="patent-data-table-td patent-date-value">Dec 9, 2008</td><td class="patent-data-table-td ">Lumera Corporation</td><td class="patent-data-table-td ">Highly stable surface plasmon resonance plates, microarrays, and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7494817">US7494817</a></td><td class="patent-data-table-td patent-date-value">Jun 30, 2005</td><td class="patent-data-table-td patent-date-value">Feb 24, 2009</td><td class="patent-data-table-td ">Transnet Yx, Inc.</td><td class="patent-data-table-td ">Mixing cellular debris and magnetically-responsive particles (having glass microfiber coating) to facilitate reversible immobilization of genomic nucleic acid; bioassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7498136">US7498136</a></td><td class="patent-data-table-td patent-date-value">Mar 16, 2006</td><td class="patent-data-table-td patent-date-value">Mar 3, 2009</td><td class="patent-data-table-td ">Eragen Biosciences, Inc.</td><td class="patent-data-table-td ">amplifying and detecting nucleic acid of Neisseria gonorrhea and a non-gonococcal species of Neisseria using specific primers for accurate diagnosis of gonorrhea</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7498342">US7498342</a></td><td class="patent-data-table-td patent-date-value">Jun 16, 2005</td><td class="patent-data-table-td patent-date-value">Mar 3, 2009</td><td class="patent-data-table-td ">Plexxikon, Inc.</td><td class="patent-data-table-td ">Compounds modulating c-kit activity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7504509">US7504509</a></td><td class="patent-data-table-td patent-date-value">Dec 17, 2004</td><td class="patent-data-table-td patent-date-value">Mar 17, 2009</td><td class="patent-data-table-td ">Plexxikon, Inc.</td><td class="patent-data-table-td ">Compounds and methods for development of Ret modulators</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7507539">US7507539</a></td><td class="patent-data-table-td patent-date-value">Jul 30, 2007</td><td class="patent-data-table-td patent-date-value">Mar 24, 2009</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Substractive single label comparative hybridization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7512496">US7512496</a></td><td class="patent-data-table-td patent-date-value">Sep 25, 2002</td><td class="patent-data-table-td patent-date-value">Mar 31, 2009</td><td class="patent-data-table-td ">Soheil Shams</td><td class="patent-data-table-td ">Apparatus, method, and computer program product for determining confidence measures and combined confidence measures for assessing the quality of microarrays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7514212">US7514212</a></td><td class="patent-data-table-td patent-date-value">Jan 17, 2004</td><td class="patent-data-table-td patent-date-value">Apr 7, 2009</td><td class="patent-data-table-td ">Eragen Biosciences, Inc.</td><td class="patent-data-table-td ">Nucleic acid amplification using non-standard bases</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7575865">US7575865</a></td><td class="patent-data-table-td patent-date-value">Aug 1, 2005</td><td class="patent-data-table-td patent-date-value">Aug 18, 2009</td><td class="patent-data-table-td ">454 Life Sciences Corporation</td><td class="patent-data-table-td ">Methods of amplifying and sequencing nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7582421">US7582421</a></td><td class="patent-data-table-td patent-date-value">Sep 16, 2002</td><td class="patent-data-table-td patent-date-value">Sep 1, 2009</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7585859">US7585859</a></td><td class="patent-data-table-td patent-date-value">May 6, 2005</td><td class="patent-data-table-td patent-date-value">Sep 8, 2009</td><td class="patent-data-table-td ">Plexxikon, Inc.</td><td class="patent-data-table-td ">PDE4B inhibitors and uses therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7597932">US7597932</a></td><td class="patent-data-table-td patent-date-value">Sep 14, 2007</td><td class="patent-data-table-td patent-date-value">Oct 6, 2009</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Mesoporous permeation layers for use on active electronic matrix devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7601301">US7601301</a></td><td class="patent-data-table-td patent-date-value">Dec 15, 2006</td><td class="patent-data-table-td patent-date-value">Oct 13, 2009</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Electrode array assembly formed on integrated circuit chip; microarrays; row decoder, column decoder, counter coupled to decoders, matrix of active biologic electrodes, memory, and digital to analog converter; monitoring reactions; used in the synthesis of biopolymer nucleic acid sequence and peptides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7601493">US7601493</a></td><td class="patent-data-table-td patent-date-value">Jul 24, 2003</td><td class="patent-data-table-td patent-date-value">Oct 13, 2009</td><td class="patent-data-table-td ">Nanogen, Inc.</td><td class="patent-data-table-td ">Methods and apparatus for screening and detecting multiple genetic mutations</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7605168">US7605168</a></td><td class="patent-data-table-td patent-date-value">Sep 2, 2005</td><td class="patent-data-table-td patent-date-value">Oct 20, 2009</td><td class="patent-data-table-td ">Plexxikon, Inc.</td><td class="patent-data-table-td ">PDE4B inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7659063">US7659063</a></td><td class="patent-data-table-td patent-date-value">Jun 14, 2004</td><td class="patent-data-table-td patent-date-value">Feb 9, 2010</td><td class="patent-data-table-td ">High Throughput Genomics, Inc.</td><td class="patent-data-table-td ">High throughput assay system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7687103">US7687103</a></td><td class="patent-data-table-td patent-date-value">Aug 28, 2007</td><td class="patent-data-table-td patent-date-value">Mar 30, 2010</td><td class="patent-data-table-td ">Gamida For Life B.V.</td><td class="patent-data-table-td ">Compositions and methods for preserving permeation layers for use on active electronic matrix devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7687239">US7687239</a></td><td class="patent-data-table-td patent-date-value">Jul 8, 2004</td><td class="patent-data-table-td patent-date-value">Mar 30, 2010</td><td class="patent-data-table-td ">Accelrs Technology Corporation</td><td class="patent-data-table-td ">Multicompartment electrophoretic apparatus for quantifying microorganisms in solution; drug screening and microbiocides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7704726">US7704726</a></td><td class="patent-data-table-td patent-date-value">Aug 17, 2006</td><td class="patent-data-table-td patent-date-value">Apr 27, 2010</td><td class="patent-data-table-td ">Gamida For Life B.V.</td><td class="patent-data-table-td ">A system for performing molecular biological diagnosis, analysis and multistep and multiplex reactions utilizes a self-addressable, self-assembling microelectronic system for actively carrying out controlled reactions in microscopic formats</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7718438">US7718438</a></td><td class="patent-data-table-td patent-date-value">Jun 20, 2001</td><td class="patent-data-table-td patent-date-value">May 18, 2010</td><td class="patent-data-table-td ">Mitsubishi Rayon Co., Ltd.</td><td class="patent-data-table-td ">Method for producing a microarray</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7778512">US7778512</a></td><td class="patent-data-table-td patent-date-value">Aug 28, 2007</td><td class="patent-data-table-td patent-date-value">Aug 17, 2010</td><td class="patent-data-table-td ">Scenterra, Inc.</td><td class="patent-data-table-td ">Light-pipe array system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7807447">US7807447</a></td><td class="patent-data-table-td patent-date-value">Nov 28, 2000</td><td class="patent-data-table-td patent-date-value">Oct 5, 2010</td><td class="patent-data-table-td ">Merck Sharp &amp; Dohme Corp.</td><td class="patent-data-table-td ">Compositions and methods for exon profiling</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7811751">US7811751</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 4, 2002</td><td class="patent-data-table-td patent-date-value">Oct 12, 2010</td><td class="patent-data-table-td ">Oxford Gene Technology Limited</td><td class="patent-data-table-td ">Labeling hybrid oligonucleotides; immobilization; sequence determination</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7820808">US7820808</a></td><td class="patent-data-table-td patent-date-value">Apr 1, 2004</td><td class="patent-data-table-td patent-date-value">Oct 26, 2010</td><td class="patent-data-table-td ">Eragen Biosciences, Inc.</td><td class="patent-data-table-td ">Antisense agent which prevents DNA replication</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7828954">US7828954</a></td><td class="patent-data-table-td patent-date-value">Sep 21, 2005</td><td class="patent-data-table-td patent-date-value">Nov 9, 2010</td><td class="patent-data-table-td ">Gamida For Life B.V.</td><td class="patent-data-table-td ">Electrode based patterning of thin film self-assembled nanoparticles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7833756">US7833756</a></td><td class="patent-data-table-td patent-date-value">Jul 8, 2008</td><td class="patent-data-table-td patent-date-value">Nov 16, 2010</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">Methods of labelling polynucleotides with dibenzorhodamine dyes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7846941">US7846941</a></td><td class="patent-data-table-td patent-date-value">May 16, 2006</td><td class="patent-data-table-td patent-date-value">Dec 7, 2010</td><td class="patent-data-table-td ">Plexxikon, Inc.</td><td class="patent-data-table-td ">Compounds modulating c-kit and c-fms activity and uses therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7863288">US7863288</a></td><td class="patent-data-table-td patent-date-value">Jun 21, 2006</td><td class="patent-data-table-td patent-date-value">Jan 4, 2011</td><td class="patent-data-table-td ">Plexxikon, Inc.</td><td class="patent-data-table-td ">protein kinase modulators such as Propane-1-sulfonic acid [2,4-difluoro-3-(5-ethoxy-1H-pyrrolo[1,3-b]pyridine-3-carbonyl)-phenyl]-amide, used to regulate signal transduction cascades, involved in the control of physiological functions including cellular growth and proliferation; anticarcinogenic agents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7863289">US7863289</a></td><td class="patent-data-table-td patent-date-value">Dec 19, 2007</td><td class="patent-data-table-td patent-date-value">Jan 4, 2011</td><td class="patent-data-table-td ">Plexxikon, Inc.</td><td class="patent-data-table-td ">Compounds and methods for kinase modulation, and indications therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7872018">US7872018</a></td><td class="patent-data-table-td patent-date-value">Dec 20, 2007</td><td class="patent-data-table-td patent-date-value">Jan 18, 2011</td><td class="patent-data-table-td ">Plexxikon, Inc.</td><td class="patent-data-table-td ">Compounds and methods for kinase modulation, and indications therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7888494">US7888494</a></td><td class="patent-data-table-td patent-date-value">Feb 6, 2004</td><td class="patent-data-table-td patent-date-value">Feb 15, 2011</td><td class="patent-data-table-td ">Oxford Gene Therapy Limited</td><td class="patent-data-table-td ">Analysing polynucleotide sequences</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7889347">US7889347</a></td><td class="patent-data-table-td patent-date-value">Nov 21, 2006</td><td class="patent-data-table-td patent-date-value">Feb 15, 2011</td><td class="patent-data-table-td ">Plexera Llc</td><td class="patent-data-table-td ">Surface plasmon resonance spectrometer with an actuator driven angle scanning mechanism</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7892743">US7892743</a></td><td class="patent-data-table-td patent-date-value">Feb 25, 2009</td><td class="patent-data-table-td patent-date-value">Feb 22, 2011</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Subtractive single label comparative hybridization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7893075">US7893075</a></td><td class="patent-data-table-td patent-date-value">Nov 21, 2007</td><td class="patent-data-table-td patent-date-value">Feb 22, 2011</td><td class="patent-data-table-td ">Plexxikon, Inc.</td><td class="patent-data-table-td ">Compounds modulating c-fms and/or c-kit activity and uses therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7935488">US7935488</a></td><td class="patent-data-table-td patent-date-value">Oct 5, 2010</td><td class="patent-data-table-td patent-date-value">May 3, 2011</td><td class="patent-data-table-td ">Keygene N.V.</td><td class="patent-data-table-td ">Selective restriction fragment amplification: fingerprinting</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7947486">US7947486</a></td><td class="patent-data-table-td patent-date-value">Feb 5, 2007</td><td class="patent-data-table-td patent-date-value">May 24, 2011</td><td class="patent-data-table-td ">Gamida For Life B.V.</td><td class="patent-data-table-td ">Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7947708">US7947708</a></td><td class="patent-data-table-td patent-date-value">Oct 2, 2008</td><td class="patent-data-table-td patent-date-value">May 24, 2011</td><td class="patent-data-table-td ">Plexxikon, Inc.</td><td class="patent-data-table-td ">Compounds modulating C-kit activity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7994296">US7994296</a></td><td class="patent-data-table-td patent-date-value">Aug 10, 2004</td><td class="patent-data-table-td patent-date-value">Aug 9, 2011</td><td class="patent-data-table-td ">Perkinelmer Health Sciences, Inc.</td><td class="patent-data-table-td ">Arrays, computer program products and methods for in silico array-based comparative binding assays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8021888">US8021888</a></td><td class="patent-data-table-td patent-date-value">Jan 26, 2006</td><td class="patent-data-table-td patent-date-value">Sep 20, 2011</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Rapid comparative genomic hybridization using acoustic surface waves</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8048623">US8048623</a></td><td class="patent-data-table-td patent-date-value">Aug 4, 2008</td><td class="patent-data-table-td patent-date-value">Nov 1, 2011</td><td class="patent-data-table-td ">The University Of North Carolina At Greensboro</td><td class="patent-data-table-td ">Compositions, products, methods and systems to monitor water and other ecosystems</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8048626">US8048626</a></td><td class="patent-data-table-td patent-date-value">Jul 27, 2007</td><td class="patent-data-table-td patent-date-value">Nov 1, 2011</td><td class="patent-data-table-td ">California Institute Of Technology</td><td class="patent-data-table-td ">Multiplex Q-PCR arrays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8067434">US8067434</a></td><td class="patent-data-table-td patent-date-value">Apr 11, 2008</td><td class="patent-data-table-td patent-date-value">Nov 29, 2011</td><td class="patent-data-table-td ">Plexxikon Inc.</td><td class="patent-data-table-td ">Compounds and methods for development of Ret modulators</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8071319">US8071319</a></td><td class="patent-data-table-td patent-date-value">Jan 28, 2008</td><td class="patent-data-table-td patent-date-value">Dec 6, 2011</td><td class="patent-data-table-td ">Accelr8 Technology Corporation</td><td class="patent-data-table-td ">Rapid microbial detection and antimicrobial susceptibiility testing</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8076074">US8076074</a></td><td class="patent-data-table-td patent-date-value">Nov 29, 2005</td><td class="patent-data-table-td patent-date-value">Dec 13, 2011</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Balanced translocation in comparative hybridization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8084197">US8084197</a></td><td class="patent-data-table-td patent-date-value">May 8, 2007</td><td class="patent-data-table-td patent-date-value">Dec 27, 2011</td><td class="patent-data-table-td ">Affymetrix, Inc.</td><td class="patent-data-table-td ">Identification of molecular sequence signatures and methods involving the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8094315">US8094315</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2008</td><td class="patent-data-table-td patent-date-value">Jan 10, 2012</td><td class="patent-data-table-td ">Plexera Llc</td><td class="patent-data-table-td ">Methods for making and using SPR microarrays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8114589">US8114589</a></td><td class="patent-data-table-td patent-date-value">Mar 22, 2007</td><td class="patent-data-table-td patent-date-value">Feb 14, 2012</td><td class="patent-data-table-td ">Gamida For Life B.V.</td><td class="patent-data-table-td ">Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8153391">US8153391</a></td><td class="patent-data-table-td patent-date-value">Aug 29, 2008</td><td class="patent-data-table-td patent-date-value">Apr 10, 2012</td><td class="patent-data-table-td ">Bunge Oils, Inc.</td><td class="patent-data-table-td ">Hydrolases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8158359">US8158359</a></td><td class="patent-data-table-td patent-date-value">Jun 24, 2010</td><td class="patent-data-table-td patent-date-value">Apr 17, 2012</td><td class="patent-data-table-td ">454 Lice Sciences Corporation</td><td class="patent-data-table-td ">Methods of amplifying and sequencing nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8227215">US8227215</a></td><td class="patent-data-table-td patent-date-value">Apr 8, 2011</td><td class="patent-data-table-td patent-date-value">Jul 24, 2012</td><td class="patent-data-table-td ">Bunge Oils, Inc.</td><td class="patent-data-table-td ">Hydrolases, nucleic acids encoding them and methods for making and using them for biocatalytic synthesis of a structured lipid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8268858">US8268858</a></td><td class="patent-data-table-td patent-date-value">Dec 20, 2007</td><td class="patent-data-table-td patent-date-value">Sep 18, 2012</td><td class="patent-data-table-td ">Plexxikon Inc.</td><td class="patent-data-table-td ">e.g. 5-(3-methoxybenzyloxy)-1H-pyrrolo[2,3-b]pyridine; protein kinases inhibitor; central nervous system disorders; Alzheimer&#39;s disease; Parkinson&#39;s disease; anticancer, antitumor agents; analgesics; cogestive heart failure; skin disorders; inflammatory bowel disorders; transplant rejection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8288155">US8288155</a></td><td class="patent-data-table-td patent-date-value">Jul 13, 2007</td><td class="patent-data-table-td patent-date-value">Oct 16, 2012</td><td class="patent-data-table-td ">Gamida For Life B.V.</td><td class="patent-data-table-td ">Biomolecular attachment sites on microelectronic arrays and methods thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8293472">US8293472</a></td><td class="patent-data-table-td patent-date-value">Jun 6, 2006</td><td class="patent-data-table-td patent-date-value">Oct 23, 2012</td><td class="patent-data-table-td ">Luminex Corporation</td><td class="patent-data-table-td ">Methods for detection and typing of nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8313918">US8313918</a></td><td class="patent-data-table-td patent-date-value">Apr 8, 2011</td><td class="patent-data-table-td patent-date-value">Nov 20, 2012</td><td class="patent-data-table-td ">Bunge Oils, Inc.</td><td class="patent-data-table-td ">Hydrolases, nucleic acids encoding them and methods to produce triglycerides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8313932">US8313932</a></td><td class="patent-data-table-td patent-date-value">Sep 17, 2010</td><td class="patent-data-table-td patent-date-value">Nov 20, 2012</td><td class="patent-data-table-td ">Luminex Corporation</td><td class="patent-data-table-td ">Polymerase inhibitor and method of using same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8313940">US8313940</a></td><td class="patent-data-table-td patent-date-value">Dec 21, 2007</td><td class="patent-data-table-td patent-date-value">Nov 20, 2012</td><td class="patent-data-table-td ">Gamida For Life B.V.</td><td class="patent-data-table-td ">Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8349578">US8349578</a></td><td class="patent-data-table-td patent-date-value">Apr 8, 2011</td><td class="patent-data-table-td patent-date-value">Jan 8, 2013</td><td class="patent-data-table-td ">Bunge Oils, Inc.</td><td class="patent-data-table-td ">Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8357503">US8357503</a></td><td class="patent-data-table-td patent-date-value">Aug 28, 2009</td><td class="patent-data-table-td patent-date-value">Jan 22, 2013</td><td class="patent-data-table-td ">Bunge Oils, Inc.</td><td class="patent-data-table-td ">Hydrolases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8383342">US8383342</a></td><td class="patent-data-table-td patent-date-value">Oct 7, 2011</td><td class="patent-data-table-td patent-date-value">Feb 26, 2013</td><td class="patent-data-table-td ">The University Of North Carolina At Greensboro</td><td class="patent-data-table-td ">Compositions, products, methods and systems to monitor water and other ecosystems</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8389212">US8389212</a></td><td class="patent-data-table-td patent-date-value">Jul 22, 1999</td><td class="patent-data-table-td patent-date-value">Mar 5, 2013</td><td class="patent-data-table-td ">Gamida For Life, B.V.</td><td class="patent-data-table-td ">Method for the electronic analysis of a sample oligonucleotide sequence</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8404700">US8404700</a></td><td class="patent-data-table-td patent-date-value">Jul 11, 2012</td><td class="patent-data-table-td patent-date-value">Mar 26, 2013</td><td class="patent-data-table-td ">Plexxikon Inc.</td><td class="patent-data-table-td ">Compounds modulating c-fms and/or c-kit activity and uses therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8415469">US8415469</a></td><td class="patent-data-table-td patent-date-value">Nov 10, 2009</td><td class="patent-data-table-td patent-date-value">Apr 9, 2013</td><td class="patent-data-table-td ">Plexxikon Inc.</td><td class="patent-data-table-td ">Compounds and methods for kinase modulation, and indications therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8420342">US8420342</a></td><td class="patent-data-table-td patent-date-value">Apr 8, 2011</td><td class="patent-data-table-td patent-date-value">Apr 16, 2013</td><td class="patent-data-table-td ">Bunge Oils, Inc.</td><td class="patent-data-table-td ">Hydrolases, nucleic acids encoding them and methods to produce triglycerides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8460887">US8460887</a></td><td class="patent-data-table-td patent-date-value">Feb 8, 2010</td><td class="patent-data-table-td patent-date-value">Jun 11, 2013</td><td class="patent-data-table-td ">Accelerate Diagnostics, Inc.</td><td class="patent-data-table-td ">Sensitive and rapid determination of antimicrobial susceptibility</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8461169">US8461169</a></td><td class="patent-data-table-td patent-date-value">Dec 1, 2010</td><td class="patent-data-table-td patent-date-value">Jun 11, 2013</td><td class="patent-data-table-td ">Plexxikon Inc.</td><td class="patent-data-table-td ">Compounds modulating c-fms and/or c-kit activity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8465942">US8465942</a></td><td class="patent-data-table-td patent-date-value">Jun 19, 2012</td><td class="patent-data-table-td patent-date-value">Jun 18, 2013</td><td class="patent-data-table-td ">Bunge Oils, Inc.</td><td class="patent-data-table-td ">Hydrolases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8470818">US8470818</a></td><td class="patent-data-table-td patent-date-value">Oct 18, 2010</td><td class="patent-data-table-td patent-date-value">Jun 25, 2013</td><td class="patent-data-table-td ">Plexxikon Inc.</td><td class="patent-data-table-td ">Compounds and methods for kinase modulation, and indications therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8470821">US8470821</a></td><td class="patent-data-table-td patent-date-value">Jul 20, 2009</td><td class="patent-data-table-td patent-date-value">Jun 25, 2013</td><td class="patent-data-table-td ">Plexxikon Inc.</td><td class="patent-data-table-td ">PDE4B inhibitors and uses therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8492089">US8492089</a></td><td class="patent-data-table-td patent-date-value">Feb 16, 2011</td><td class="patent-data-table-td patent-date-value">Jul 23, 2013</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Subtractive single label comparative hybridization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8541191">US8541191</a></td><td class="patent-data-table-td patent-date-value">Apr 8, 2011</td><td class="patent-data-table-td patent-date-value">Sep 24, 2013</td><td class="patent-data-table-td ">Bunge Oils, Inc.</td><td class="patent-data-table-td ">Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8580501">US8580501</a></td><td class="patent-data-table-td patent-date-value">May 21, 2008</td><td class="patent-data-table-td patent-date-value">Nov 12, 2013</td><td class="patent-data-table-td ">Decode Genetics Ehf.</td><td class="patent-data-table-td ">Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8618248">US8618248</a></td><td class="patent-data-table-td patent-date-value">Oct 30, 2007</td><td class="patent-data-table-td patent-date-value">Dec 31, 2013</td><td class="patent-data-table-td ">President And Fellows Of Harvard College</td><td class="patent-data-table-td ">Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8697360">US8697360</a></td><td class="patent-data-table-td patent-date-value">Nov 26, 2008</td><td class="patent-data-table-td patent-date-value">Apr 15, 2014</td><td class="patent-data-table-td ">Decode Genetics Ehf.</td><td class="patent-data-table-td ">Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8697362">US8697362</a></td><td class="patent-data-table-td patent-date-value">Oct 17, 2007</td><td class="patent-data-table-td patent-date-value">Apr 15, 2014</td><td class="patent-data-table-td ">Caliper Life Sciences, Inc.</td><td class="patent-data-table-td ">Methods of detecting low copy nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8722702">US8722702</a></td><td class="patent-data-table-td patent-date-value">Feb 25, 2013</td><td class="patent-data-table-td patent-date-value">May 13, 2014</td><td class="patent-data-table-td ">Plexxikon Inc.</td><td class="patent-data-table-td ">Compounds modulating c-fms and/or c-kit activity and uses therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8741920">US8741920</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2012</td><td class="patent-data-table-td patent-date-value">Jun 3, 2014</td><td class="patent-data-table-td ">Hoffmann-La Roche, Inc.</td><td class="patent-data-table-td ">Process for the manufacture of pharmaceutically active compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8772467">US8772467</a></td><td class="patent-data-table-td patent-date-value">Oct 7, 2009</td><td class="patent-data-table-td patent-date-value">Jul 8, 2014</td><td class="patent-data-table-td ">Gamida For Life B.V.</td><td class="patent-data-table-td ">Methods and apparatus for screening and detecting multiple genetic mutations</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20100216660">US20100216660</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 19, 2007</td><td class="patent-data-table-td patent-date-value">Aug 26, 2010</td><td class="patent-data-table-td ">Yuri Nikolsky</td><td class="patent-data-table-td ">Novel methods for functional analysis of high-throughput experimental data and gene groups identified therefrom</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2112227A1?cl=en">EP2112227A1</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 2007</td><td class="patent-data-table-td patent-date-value">Oct 28, 2009</td><td class="patent-data-table-td ">Cargill, Incorporated</td><td class="patent-data-table-td ">Aldolases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2194133A2?cl=en">EP2194133A2</a></td><td class="patent-data-table-td patent-date-value">Mar 8, 2004</td><td class="patent-data-table-td patent-date-value">Jun 9, 2010</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Amylases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2216403A2?cl=en">EP2216403A2</a></td><td class="patent-data-table-td patent-date-value">Feb 2, 2007</td><td class="patent-data-table-td patent-date-value">Aug 11, 2010</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Esterases and related nucleic acids and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2263791A2?cl=en">EP2263791A2</a></td><td class="patent-data-table-td patent-date-value">Sep 25, 2001</td><td class="patent-data-table-td patent-date-value">Dec 22, 2010</td><td class="patent-data-table-td ">Picoliter Inc.</td><td class="patent-data-table-td ">Acoustic ejection of fluids from reservoirs</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2280085A2?cl=en">EP2280085A2</a></td><td class="patent-data-table-td patent-date-value">Nov 1, 2005</td><td class="patent-data-table-td patent-date-value">Feb 2, 2011</td><td class="patent-data-table-td ">George Mason University</td><td class="patent-data-table-td ">Compositions and methods for diagnosing colon disorders</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2298871A1?cl=en">EP2298871A1</a></td><td class="patent-data-table-td patent-date-value">Apr 21, 2003</td><td class="patent-data-table-td patent-date-value">Mar 23, 2011</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Phospholipases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2316962A1?cl=en">EP2316962A1</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 2007</td><td class="patent-data-table-td patent-date-value">May 4, 2011</td><td class="patent-data-table-td ">Cargill, Incorporated</td><td class="patent-data-table-td ">Aldolases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2322643A1?cl=en">EP2322643A1</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 2007</td><td class="patent-data-table-td patent-date-value">May 18, 2011</td><td class="patent-data-table-td ">Cargill, Incorporated</td><td class="patent-data-table-td ">Aldolases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2341136A1?cl=en">EP2341136A1</a></td><td class="patent-data-table-td patent-date-value">Apr 2, 2004</td><td class="patent-data-table-td patent-date-value">Jul 6, 2011</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Pectate lyases, Nucleic Acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2366801A1?cl=en">EP2366801A1</a></td><td class="patent-data-table-td patent-date-value">Jun 14, 2007</td><td class="patent-data-table-td patent-date-value">Sep 21, 2011</td><td class="patent-data-table-td ">Verinata Health, Inc</td><td class="patent-data-table-td ">Methods for the diagnosis of fetal abnormalities</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2385108A1?cl=en">EP2385108A1</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 2007</td><td class="patent-data-table-td patent-date-value">Nov 9, 2011</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Aldolases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2388316A2?cl=en">EP2388316A2</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 2007</td><td class="patent-data-table-td patent-date-value">Nov 23, 2011</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Aldolases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2404928A1?cl=en">EP2404928A1</a></td><td class="patent-data-table-td patent-date-value">Jul 2, 2004</td><td class="patent-data-table-td patent-date-value">Jan 11, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Glucanases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2404929A1?cl=en">EP2404929A1</a></td><td class="patent-data-table-td patent-date-value">Jul 2, 2004</td><td class="patent-data-table-td patent-date-value">Jan 11, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Glucanases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2404930A1?cl=en">EP2404930A1</a></td><td class="patent-data-table-td patent-date-value">Jul 2, 2004</td><td class="patent-data-table-td patent-date-value">Jan 11, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Glucanases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2404931A1?cl=en">EP2404931A1</a></td><td class="patent-data-table-td patent-date-value">Jul 2, 2004</td><td class="patent-data-table-td patent-date-value">Jan 11, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Glucanases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2409981A1?cl=en">EP2409981A1</a></td><td class="patent-data-table-td patent-date-value">Jul 2, 2004</td><td class="patent-data-table-td patent-date-value">Jan 25, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Glucanases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2415864A1?cl=en">EP2415864A1</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2006</td><td class="patent-data-table-td patent-date-value">Feb 8, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Oligomerase-2 (or beta-xylosidase) enzymes, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2420570A1?cl=en">EP2420570A1</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2006</td><td class="patent-data-table-td patent-date-value">Feb 22, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Arabinofuranosidase enzymes, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2444487A1?cl=en">EP2444487A1</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2006</td><td class="patent-data-table-td patent-date-value">Apr 25, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2444488A1?cl=en">EP2444488A1</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2006</td><td class="patent-data-table-td patent-date-value">Apr 25, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Cellucloytic enzymes, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2444489A1?cl=en">EP2444489A1</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2006</td><td class="patent-data-table-td patent-date-value">Apr 25, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Cellucloytic enzymes, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2444490A1?cl=en">EP2444490A1</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2006</td><td class="patent-data-table-td patent-date-value">Apr 25, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2447363A1?cl=en">EP2447363A1</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2006</td><td class="patent-data-table-td patent-date-value">May 2, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Cellucloytic enzymes, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2450439A1?cl=en">EP2450439A1</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2006</td><td class="patent-data-table-td patent-date-value">May 9, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2468853A1?cl=en">EP2468853A1</a></td><td class="patent-data-table-td patent-date-value">Jun 14, 2005</td><td class="patent-data-table-td patent-date-value">Jun 27, 2012</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Composition and methods for enzymatic decolorization of chlorophyll</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2535425A1?cl=en">EP2535425A1</a></td><td class="patent-data-table-td patent-date-value">May 21, 2008</td><td class="patent-data-table-td patent-date-value">Dec 19, 2012</td><td class="patent-data-table-td ">Decode Genetics EHF.</td><td class="patent-data-table-td ">Variantes génétiques sur les chr 10q26 utilisées comme marqueurs dans l&#39;évaluation, le diagnostic, le pronostic et le traitement d&#39;un risque de cancer du sein</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2589668A1?cl=en">EP2589668A1</a></td><td class="patent-data-table-td patent-date-value">Jun 14, 2007</td><td class="patent-data-table-td patent-date-value">May 8, 2013</td><td class="patent-data-table-td ">Verinata Health, Inc</td><td class="patent-data-table-td ">Rare cell analysis using sample splitting and DNA tags</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2708602A2?cl=en">EP2708602A2</a></td><td class="patent-data-table-td patent-date-value">Aug 1, 2008</td><td class="patent-data-table-td patent-date-value">Mar 19, 2014</td><td class="patent-data-table-td ">Verenium Corporation</td><td class="patent-data-table-td ">Xylanases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2000053811A1?cl=en">WO2000053811A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 9, 2000</td><td class="patent-data-table-td patent-date-value">Sep 14, 2000</td><td class="patent-data-table-td ">Orion Genomics Llc</td><td class="patent-data-table-td ">Genome chips and optical transcript mapping</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2002020842A1?cl=en">WO2002020842A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 4, 2001</td><td class="patent-data-table-td patent-date-value">Mar 14, 2002</td><td class="patent-data-table-td ">Timothy A Hodge</td><td class="patent-data-table-td ">System, method and apparatus for transgenic and targeted mutagenesis screening</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2002072886A2?cl=en">WO2002072886A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 7, 2002</td><td class="patent-data-table-td patent-date-value">Sep 19, 2002</td><td class="patent-data-table-td ">Peter Estibeiro</td><td class="patent-data-table-td ">Complex element micro-array and methods of use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2003074544A1?cl=en">WO2003074544A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 27, 2003</td><td class="patent-data-table-td patent-date-value">Sep 12, 2003</td><td class="patent-data-table-td ">Applera Corp</td><td class="patent-data-table-td ">Methods of using unnatural nucleobases for decoding</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2004090099A2?cl=en">WO2004090099A2</a></td><td class="patent-data-table-td patent-date-value">Apr 2, 2004</td><td class="patent-data-table-td patent-date-value">Oct 21, 2004</td><td class="patent-data-table-td ">Diversa Corp</td><td class="patent-data-table-td ">Pectate lyases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2006009676A2?cl=en">WO2006009676A2</a></td><td class="patent-data-table-td patent-date-value">Jun 14, 2005</td><td class="patent-data-table-td patent-date-value">Jan 26, 2006</td><td class="patent-data-table-td ">Diversa Corp</td><td class="patent-data-table-td ">Compositions and methods for enzymatic decolorization of chlorophyll</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2006101584A2?cl=en">WO2006101584A2</a></td><td class="patent-data-table-td patent-date-value">Jan 13, 2006</td><td class="patent-data-table-td patent-date-value">Sep 28, 2006</td><td class="patent-data-table-td ">Diversa Corp</td><td class="patent-data-table-td ">Cellulases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2007013896A2?cl=en">WO2007013896A2</a></td><td class="patent-data-table-td patent-date-value">May 16, 2006</td><td class="patent-data-table-td patent-date-value">Feb 1, 2007</td><td class="patent-data-table-td ">Plexxikon Inc</td><td class="patent-data-table-td ">Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2007070553A2?cl=en">WO2007070553A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 12, 2006</td><td class="patent-data-table-td patent-date-value">Jun 21, 2007</td><td class="patent-data-table-td ">Univ Johns Hopkins</td><td class="patent-data-table-td ">Double-tiled and multi-tiled arrays and methods thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2007147079A2?cl=en">WO2007147079A2</a></td><td class="patent-data-table-td patent-date-value">Jun 14, 2007</td><td class="patent-data-table-td patent-date-value">Dec 21, 2007</td><td class="patent-data-table-td ">Living Microsystems Inc</td><td class="patent-data-table-td ">Rare cell analysis using sample splitting and dna tags</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2008036916A2?cl=en">WO2008036916A2</a></td><td class="patent-data-table-td patent-date-value">Sep 21, 2007</td><td class="patent-data-table-td patent-date-value">Mar 27, 2008</td><td class="patent-data-table-td ">Verenium Corp</td><td class="patent-data-table-td ">Phytases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2008079972A2?cl=en">WO2008079972A2</a></td><td class="patent-data-table-td patent-date-value">Dec 20, 2007</td><td class="patent-data-table-td patent-date-value">Jul 3, 2008</td><td class="patent-data-table-td ">Bayer Pharmaceuticals Corp</td><td class="patent-data-table-td ">4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2008146309A2?cl=en">WO2008146309A2</a></td><td class="patent-data-table-td patent-date-value">May 21, 2008</td><td class="patent-data-table-td patent-date-value">Dec 4, 2008</td><td class="patent-data-table-td ">Decode Genetics Ehf</td><td class="patent-data-table-td ">Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2009045627A2?cl=en">WO2009045627A2</a></td><td class="patent-data-table-td patent-date-value">Aug 1, 2008</td><td class="patent-data-table-td patent-date-value">Apr 9, 2009</td><td class="patent-data-table-td ">Verenium Corp</td><td class="patent-data-table-td ">Xylanases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2009069152A2?cl=en">WO2009069152A2</a></td><td class="patent-data-table-td patent-date-value">Dec 5, 2008</td><td class="patent-data-table-td patent-date-value">Jun 4, 2009</td><td class="patent-data-table-td ">Decode Genetics Ehf</td><td class="patent-data-table-td ">Genetic variants on chr hq and 6q as markers for prostate and colorectal cancer predisposition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2009088949A1?cl=en">WO2009088949A1</a></td><td class="patent-data-table-td patent-date-value">Dec 31, 2008</td><td class="patent-data-table-td patent-date-value">Jul 16, 2009</td><td class="patent-data-table-td ">Verenium Corp</td><td class="patent-data-table-td ">Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011038360A1?cl=en">WO2011038360A1</a></td><td class="patent-data-table-td patent-date-value">Sep 27, 2010</td><td class="patent-data-table-td patent-date-value">Mar 31, 2011</td><td class="patent-data-table-td ">Signature Genomics Laboratories Llc</td><td class="patent-data-table-td ">Multiplex (+/-) stranded arrays and assays for detecting chromosomal abnormalities associated with cancer and other diseases</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011046815A1?cl=en">WO2011046815A1</a></td><td class="patent-data-table-td patent-date-value">Oct 8, 2010</td><td class="patent-data-table-td patent-date-value">Apr 21, 2011</td><td class="patent-data-table-td ">Bunge Oils, Inc.</td><td class="patent-data-table-td ">Oil degumming methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011048495A1?cl=en">WO2011048495A1</a></td><td class="patent-data-table-td patent-date-value">Oct 19, 2010</td><td class="patent-data-table-td patent-date-value">Apr 28, 2011</td><td class="patent-data-table-td ">Stichting Het Nederlands Kanker Instituut</td><td class="patent-data-table-td ">Predicting benefit of anti-cancer therapy via array comparative genomic hybridization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011048498A2?cl=en">WO2011048498A2</a></td><td class="patent-data-table-td patent-date-value">Oct 19, 2010</td><td class="patent-data-table-td patent-date-value">Apr 28, 2011</td><td class="patent-data-table-td ">Stichting Het Nederlands Kanker Instituut</td><td class="patent-data-table-td ">Differentiation between brca2-associated tumours and sporadic tumours via array comparative genomic hybridization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011048499A1?cl=en">WO2011048499A1</a></td><td class="patent-data-table-td patent-date-value">Oct 19, 2010</td><td class="patent-data-table-td patent-date-value">Apr 28, 2011</td><td class="patent-data-table-td ">Stichting Het Nederlands Kanker Instituut</td><td class="patent-data-table-td ">Predicting response to anti-cancer therapy via array comparative genomic hybridization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011130728A1?cl=en">WO2011130728A1</a></td><td class="patent-data-table-td patent-date-value">Apr 18, 2011</td><td class="patent-data-table-td patent-date-value">Oct 20, 2011</td><td class="patent-data-table-td ">Bayer Healthcare Llc</td><td class="patent-data-table-td ">Synthetic metabolites of fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention diseases and conditions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012038837A2?cl=en">WO2012038837A2</a></td><td class="patent-data-table-td patent-date-value">Sep 20, 2011</td><td class="patent-data-table-td patent-date-value">Mar 29, 2012</td><td class="patent-data-table-td ">Stichting Het Nederlands Kanker Instituut</td><td class="patent-data-table-td ">Methods for predicting response to anti-cancer therapy in cancer patients</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012051055A2?cl=en">WO2012051055A2</a></td><td class="patent-data-table-td patent-date-value">Oct 6, 2011</td><td class="patent-data-table-td patent-date-value">Apr 19, 2012</td><td class="patent-data-table-td ">Bp Corporation North America Inc.</td><td class="patent-data-table-td ">Variant cbh i polypeptides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014074942A1?cl=en">WO2014074942A1</a></td><td class="patent-data-table-td patent-date-value">Nov 8, 2013</td><td class="patent-data-table-td patent-date-value">May 15, 2014</td><td class="patent-data-table-td ">Illumina, Inc.</td><td class="patent-data-table-td ">Risk variants of alzheimer&#39;s disease</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014080182A1?cl=en">WO2014080182A1</a></td><td class="patent-data-table-td patent-date-value">Nov 14, 2013</td><td class="patent-data-table-td patent-date-value">May 30, 2014</td><td class="patent-data-table-td ">The Institute Of Cancer: Royal Cancer Hospital</td><td class="patent-data-table-td ">Materials and methods for determining susceptibility or predisposition to cancer</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S006120">435/6.12</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc422/defs422.htm&usg=AFQjCNHXLT_uXJvUp9ERMJkh6x6moeyOWg#C422S068100">422/68.1</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S025300">536/25.3</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S024320">536/24.32</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S024310">536/24.31</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S024300">536/24.3</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S023100">536/23.1</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S024100">536/24.1</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S024330">536/24.33</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc422/defs422.htm&usg=AFQjCNHXLT_uXJvUp9ERMJkh6x6moeyOWg#C422S050000">422/50</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C40B0040060000">C40B40/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=B01J0019000000">B01J19/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12Q0001680000">C12Q1/68</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C40B0060140000">C40B60/14</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00637">B01J2219/00637</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00596">B01J2219/00596</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C40B60/14">C40B60/14</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C40B40/06">C40B40/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00605">B01J2219/00605</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J19/0046">B01J19/0046</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00527">B01J2219/00527</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00722">B01J2219/00722</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00612">B01J2219/00612</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00626">B01J2219/00626</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00529">B01J2219/00529</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00385">B01J2219/00385</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00659">B01J2219/00659</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/0043">B01J2219/0043</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00689">B01J2219/00689</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00608">B01J2219/00608</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01J2219/00644">B01J2219/00644</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=y-xOBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12Q1/6837">C12Q1/6837</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">B01J19/00C</span>, <span class="nested-value">C12Q1/68B10A</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Jun 12, 2012</td><td class="patent-data-table-td ">FP</td><td class="patent-data-table-td ">Expired due to failure to pay maintenance fee</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20120425</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 25, 2012</td><td class="patent-data-table-td ">LAPS</td><td class="patent-data-table-td ">Lapse for failure to pay maintenance fees</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 5, 2011</td><td class="patent-data-table-td ">REMI</td><td class="patent-data-table-td ">Maintenance fee reminder mailed</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Aug 18, 2009</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 1-2 AND 9-10 ARE CANCELLED. CLAIM 3 IS DETERMINED TO BE PATENTABLE AS AMENDED. CLAIMS 4-8, DEPENDENT ON AN AMENDED CLAIM, ARE DETERMINED TO BE PATENTABLE. CLAIMS 11 AND 12 WERE NOT REEXAMINED.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 27, 2007</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20071009</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 6, 2007</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20070904</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 17, 2007</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 17, 2007</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20070116</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 29, 2003</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U25wojIbtOvxyZyP2Tnj33jhHuElQ\u0026id=y-xOBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U2vSCQx_0YFKiEVgD_TIkM7eJZeSg\u0026id=y-xOBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U1IQzABh-lwE72nQV48TxL1XnMbyg","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Patterning_of_oligonucleotides_on_surfac.pdf?id=y-xOBAABERAJ\u0026output=pdf\u0026sig=ACfU3U2wOQTycusGXpX0xz4JJCIeitfyKA"},"sample_url":"http://www.google.com/patents/reader?id=y-xOBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>